TW202134347A - Polyamide molding compounds for hypochlorite-resistant applications - Google Patents

Polyamide molding compounds for hypochlorite-resistant applications Download PDF

Info

Publication number
TW202134347A
TW202134347A TW109145569A TW109145569A TW202134347A TW 202134347 A TW202134347 A TW 202134347A TW 109145569 A TW109145569 A TW 109145569A TW 109145569 A TW109145569 A TW 109145569A TW 202134347 A TW202134347 A TW 202134347A
Authority
TW
Taiwan
Prior art keywords
acid
polyamide
macmi
macmt
particularly preferably
Prior art date
Application number
TW109145569A
Other languages
Chinese (zh)
Inventor
阿爾達 阿爾坎
湯瑪士 威德曼
安德里 加德伯特
曼菲德 黑維爾
波多 霍夫曼
Original Assignee
瑞士商Ems化學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瑞士商Ems化學股份有限公司 filed Critical 瑞士商Ems化學股份有限公司
Publication of TW202134347A publication Critical patent/TW202134347A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L77/00Compositions of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Compositions of derivatives of such polymers
    • C08L77/06Polyamides derived from polyamines and polycarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L77/00Compositions of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Compositions of derivatives of such polymers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L77/00Compositions of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Compositions of derivatives of such polymers
    • C08L77/02Polyamides derived from omega-amino carboxylic acids or from lactams thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/26Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids
    • C08G69/265Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids from at least two different diamines or at least two different dicarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K7/00Use of ingredients characterised by shape
    • C08K7/02Fibres or whiskers
    • C08K7/04Fibres or whiskers inorganic
    • C08K7/14Glass
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00Polymer mixtures characterised by other features
    • C08L2205/02Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00Polymer mixtures characterised by other features
    • C08L2205/03Polymer mixtures characterised by other features containing three or more polymers in a blend

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyamides (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

The present invention relates to the use of a polyamide molding compound for application purposes in which high resistance to hypochlorous acid is crucial. The molding compound is thus used according to the invention for molded bodies suitable for being in contact with aqueous, hypochlorous acid-containing solutions.

Description

用於抗次氯酸鹽應用之聚醯胺模制化合物 Polyamide molding compound for anti-hypochlorite applications

本發明涉及聚醯胺模制化合物之應用目的之用途,於其中對次氯酸之高耐受性係至關重要。因此,根據本發明,該模制化合物係用於適合與含次氯酸之水溶液接觸之模製體。 The present invention relates to the use of polyamide molding compounds for the purpose of application, in which high tolerance to hypochlorous acid is essential. Therefore, according to the present invention, the molding compound is used for a molded body suitable for contact with an aqueous solution containing hypochlorous acid.

EP 1 291 073 A1涉及聚醯胺微膠囊(polyamide microcapsules),該聚醯胺微膠囊係藉由將含有二胺和陰離子聚合物及/或異元多醣(heteropolysaccharides)之溶解形式之水相與含有溶解之二羧酸鹵化物之油相接觸,形成W/O乳液,用鈣鹽溶液硬化,並過濾、洗滌以及乾燥而獲得。聚醯胺微膠囊被敘述為對次氯酸鹼液(hypochlorite lye)穩定,以及被用於化妝品之用途。 EP 1 291 073 A1 relates to polyamide microcapsules (polyamide microcapsules), the polyamide microcapsules are made by combining diamines and anionic polymers and/or heteropolysaccharides in a dissolved form with an aqueous phase containing The oil phase of the dissolved dicarboxylic acid halide is contacted to form a W/O emulsion, which is hardened with a calcium salt solution, filtered, washed and dried. Polyamide microcapsules are described as stable to hypochlorite lye and used in cosmetics.

EP 3 502 188 A1涉及一聚醯胺模制化合物,特別是用於飲用水領域,即用於生產模製部件,其中,當按意圖使用時,加工後之模制化合物與飲用水接觸。但是,並未提到對次氯酸鹽之耐受性,亦未提到聚醯胺模制化合物在按意圖使用時,用於與含次氯酸鹽溶液接觸之模製體之用途。 EP 3 502 188 A1 relates to a polyamide molding compound, especially for use in the field of drinking water, that is, for the production of molded parts, where, when used as intended, the processed molding compound comes into contact with drinking water. However, there is no mention of the resistance to hypochlorite, and the use of the polyamide molding compound in the molded body in contact with the hypochlorite-containing solution when used as intended.

適合用於生產具有高玻璃轉換溫度、剛性和抗衝擊性以及低吸濕性之模製體之共聚醯胺,可從EP 0 469 435 A1中得知。此外,揭露了生 產該等共聚醯胺之方法及其用於生產模製體之用途。 Copolyamides suitable for producing molded bodies with high glass transition temperature, rigidity and impact resistance and low moisture absorption can be known from EP 0 469 435 A1. In addition, it exposes the health The method of producing these copolyamides and their use in producing molded bodies.

由此開始,本發明之目的係找到合適之聚醯胺模制化合物,其允許該化合物在使用過程中暴露於含次氯酸鹽溶液之用途。在此過程中,相對於從先前技術中已知之應用,該用途之意圖係提供增強之穩定性。此處增強之穩定性應指當根據本發明之模制化合物被儲存在含次氯酸鹽溶液中時,重量之變化盡可能低。此外,就機械性(mechanics)而言,根據本發明之模制化合物之特徵為增強之穩定性,尤其是拉伸力(tensile force)。 Starting from this, the object of the present invention is to find a suitable polyamide molding compound that allows the compound to be exposed to hypochlorite-containing solutions during use. In this process, the purpose of this use is to provide enhanced stability relative to the applications known from the prior art. The enhanced stability here shall mean that when the molding compound according to the present invention is stored in a hypochlorite-containing solution, the change in weight is as low as possible. In addition, in terms of mechanics, the molding compound according to the present invention is characterized by enhanced stability, especially tensile force.

此標的係藉由申請專利範圍第1項之特徵而實現。附屬請求項涉及有利之改進。 This target is realized by the feature of item 1 in the scope of patent application. The ancillary claims involve favorable improvements.

術語之定義 Definition of terms

用於該等聚醯胺及其單體之名稱和縮寫 Used in the names and abbreviations of these polyamides and their monomers

在本發明之含義內,術語「聚醯胺」(縮寫:PA)應被理解為意指包括同元聚醯胺(homopolyamides)和共聚醯胺(copolyamides)之通用術語。該等聚醯胺及其單體之選定名稱和縮寫係對應於ISO標準1874-1(2011,(D))中所確立者。其中所使用之縮寫在下文中同義地被使用作為單體之IUPAC名稱。尤其是,本申請案中出現之單體之縮寫如下:MACM代表雙(4-胺基-3-甲基環己基)甲烷(bis(4-amino-3-methylcyclohexyl)methane)(亦稱為3,3'-二甲基-4,4'-二胺基二環己基甲烷(3,3'-dimethyl-4,4'-diaminodicyclohexylmethane),CAS No.6864-37-5),TMDC代表雙(4-胺基-3,5-二甲基環己基)甲烷(bis(4-amino-3,5-dimethylcyclohexyl)methane)(亦稱為3,3',5,5'-四甲基-4,4'-二 胺基二環己基甲烷(3,3',5,5'-tetramethyl-4,4'-diaminodicyclohexylmethane),CAS No.65962-45-0),PACM代表雙(4-胺基環己基)甲烷(bis(4-aminocyclohexyl)methane)(亦稱為4,4'-二胺基二環己基甲烷(4,4'-diaminodicyclohexylmethane),CAS No.1761-71-3),BAC代表1,3-雙(胺基甲基)環己烷(1,3-bis(aminomethyl)cyclohexane)(亦稱為1,3-環己烷二甲胺(1,3-cyclohexanedimethanamine),CAS-No.2579-20-6),以及代表1,4-雙(胺基甲基)環己烷(1,4-bis(aminomethyl)cyclohexane)(亦稱為1,4-環己烷二甲胺(1,4-cyclohexanedimethanamine),CAS No.2549-93-1)以及代表其混合物,IPD代表異佛爾酮二胺(isophorone diamine)(亦稱為3-(胺基甲基)-3,5,5-三甲基環己胺(3-(aminomethyl)-3,5,5-trimethylcyclohexanamine)、1-胺基-3-胺基甲基-3,5,5-三甲基環己烷(1-amino-3-aminomethyl-3,5,5-trimethylcyclohexane)或環己烷甲胺(cyclohexanemethanamine)、5-胺基-1,3,5,5-三甲基(5-amino-1,3,5,5-trimethyl),CAS-Nr.2855-13-2),T代表對苯二甲酸(terephthalic acid)(CAS No.100-21-0),I代表間苯二甲酸(isophthalic acid)(CAS No.121-95-5),36代表具有36個碳原子之二聚脂肪酸(CAS-Nr.68783-41-5或61788-89-4),12代表十二烷二酸(dodecanedioic acid)(亦稱為1,10-癸二羧酸(1,10-decanedicarboxylic acid),CAS No.693-23-2),CHD代表1,4-環己烷二羧酸(1,4-cyclohexanedicarboxylic acid)(CAS No.1076-97-7),12代表內醯胺-12(Lactam-12)(亦稱為月桂脂內醯胺(laurin lactam),CAS No.947-04-6)。 Within the meaning of the present invention, the term "polyamide" (abbreviation: PA) should be understood to mean a general term including homopolyamides and copolyamides. The selected names and abbreviations of these polyamides and their monomers correspond to those established in the ISO standard 1874-1 (2011, (D)). The abbreviations used therein are used synonymously as the IUPAC name of the monomer in the following. In particular, the abbreviations of the monomers appearing in this application are as follows: MACM stands for bis(4-amino-3-methylcyclohexyl)methane (also known as 3 ,3'-dimethyl-4,4'-diaminodicyclohexylmethane (3,3'-dimethyl-4,4'-diaminodicyclohexylmethane), CAS No.6864-37-5), TMDC stands for double ( 4-amino-3,5-dimethylcyclohexyl)methane (bis(4-amino-3,5-dimethylcyclohexyl)methane) (also known as 3,3',5,5'-tetramethyl-4 ,4'-diaminodicyclohexylmethane (3,3',5,5'-tetramethyl-4,4'-diaminodicyclohexylmethane), CAS No.65962-45-0), PACM stands for bis(4-amino Cyclohexyl) methane (bis(4-aminocyclohexyl)methane) (also known as 4,4'-diaminodicyclohexylmethane (4,4'-diaminodicyclohexylmethane), CAS No. 1761-71-3), represented by BAC 1,3-bis(aminomethyl)cyclohexane (1,3-bis(aminomethyl)cyclohexane) (also known as 1,3-cyclohexanedimethanamine), CAS-No .2579-20-6), and represents 1,4-bis(aminomethyl)cyclohexane (1,4-bis(aminomethyl)cyclohexane) (also known as 1,4-cyclohexanedimethylamine ( 1,4-cyclohexanedimethanamine), CAS No. 2549-93-1 ) and on behalf of its mixture, IPD stands for isophorone diamine (isophorone diamine) (also known as 3-(aminomethyl)-3,5, 5-trimethylcyclohexylamine (3-(aminomethyl)-3,5,5-trimethylcyclohexanamine), 1-amino-3-aminomethyl-3,5,5-trimethylcyclohexanamine (1 -amino-3-aminomethyl-3,5,5-trimethylcyclohexane) or cyclohexanemethanamine (cyclohexanemethanamine), 5-amino-1,3,5,5-trimethyl (5-amino-1,3, 5,5-trimethyl), CAS-Nr. 2855-13-2), T represents terephthalic acid (terephth alic acid) (CAS No. 100-21-0), I stands for isophthalic acid (CAS No. 121-95-5), 36 stands for dimerized fatty acid with 36 carbon atoms (CAS-Nr .68783-41-5 or 61788-89-4), 12 represents dodecanedioic acid (also known as 1,10-decanedicarboxylic acid), CAS No.693 -23-2), CHD stands for 1,4-cyclohexanedicarboxylic acid (CAS No.1076-97-7), 12 stands for Lactam-12 (Lactam-12) ( Also known as laurin lactam (CAS No. 947-04-6).

該等非晶質或微晶聚醯胺 These amorphous or microcrystalline polyamides

該等非晶質或微晶聚醯胺,在根據ISO 11357-2(2013)之差 示掃描量熱法(differential scanning calorimetry,DSC)中,在20K/min之加熱速率下,較佳顯示出不大於28J/g,特別是不大於25J/g,以及最特別是0至23J/g之熔合熱(heat of fusion)。 The difference between these amorphous or microcrystalline polyamides in accordance with ISO 11357-2 (2013) In differential scanning calorimetry (DSC), at a heating rate of 20K/min, it is better to show no more than 28J/g, especially no more than 25J/g, and most particularly 0 to 23J/g The heat of fusion.

該等微晶聚醯胺是半結晶聚醯胺,並且因此具有熔點。然而,其形態係如此,即微晶體(crystallites)具有如此小之尺寸,而根據ASTM D 1003-13(2013)測量,其所生產之具有2mm厚度之板子仍然是透明的,即其透光率(light transmission)為至少80%,較佳為至少85%,以及特別較佳為至少90%。 These microcrystalline polyamides are semi-crystalline polyamides and therefore have a melting point. However, its morphology is such that the crystallites have such a small size, and according to ASTM D 1003-13 (2013) measurement, the plate with a thickness of 2mm produced by it is still transparent, that is, it transmits light. The light transmission is at least 80%, preferably at least 85%, and particularly preferably at least 90%.

根據本發明,用於該等聚醯胺模制化合物之該等微晶聚醯胺之熔化溫度,根據ISO 11357-3(2013)測量,較佳為不大於255℃。 According to the present invention, the melting temperature of the microcrystalline polyamide used in the polyamide molding compound, measured according to ISO 11357-3 (2013), is preferably not greater than 255°C.

與該等微晶聚醯胺相較,該等非晶質聚醯胺具有較低之熔合熱。在根據ISO 11357-2(2013)之差示掃描量熱法(DSC)中,在加熱速率為20K/min下,該等非晶質微晶聚醯胺較佳為顯示出不大於5J/g之熔合熱,特別較佳為不大於3J/g,以及最特別較佳為0至1J/g。 Compared with the microcrystalline polyamides, the amorphous polyamides have a lower heat of fusion. In the differential scanning calorimetry (DSC) according to ISO 11357-2 (2013), at a heating rate of 20K/min, the amorphous microcrystalline polyamides preferably exhibit no more than 5J/g The heat of fusion is particularly preferably not more than 3 J/g, and most particularly preferably 0 to 1 J/g.

該等非晶質聚醯胺因其非晶性(amorphicity)而無熔化溫度。 These amorphous polyamides have no melting temperature due to their amorphicity.

根據ASTM D 1003-13(2013),在2mm厚度之板子上測量,該等非晶質聚醯胺是透明的,即其透光率為至少80%,較佳為至少85%,以及特別較佳為至少90%。 According to ASTM D 1003-13 (2013), measured on a 2mm thick board, the amorphous polyamide is transparent, that is, its light transmittance is at least 80%, preferably at least 85%, and particularly Preferably, it is at least 90%.

該等半結晶聚醯胺 Semi-crystalline polyamide

在本發明之含義內,半結晶聚醯胺係指在根據ISO 11357-2(2013)之差示掃描量熱法(DSC)中,在20K/min之加熱速率下,較佳為具有至少30J/g,特別較佳為至少35J/g,以及最特別較佳為至少40J/g之熔合熱 之聚醯胺。根據ASTM D 1003-13(2013)測量,由該等半結晶聚醯胺製成之厚度為2mm之板子係不透明,即其透光率小於80%,較佳為小於70%,以及特別較佳為小於60%。 Within the meaning of the present invention, semi-crystalline polyamide means that in the differential scanning calorimetry (DSC) according to ISO 11357-2 (2013), at a heating rate of 20K/min, it preferably has at least 30J /g, particularly preferably at least 35J/g, and most particularly preferably at least 40J/g of fusion heat The polyamide. According to ASTM D 1003-13 (2013) measurement, the thickness of the board made of the semi-crystalline polyamide of 2mm is opaque, that is, its light transmittance is less than 80%, preferably less than 70%, and particularly preferably It is less than 60%.

該等半結晶聚醯胺具有一熔化溫度。 The semi-crystalline polyamides have a melting temperature.

二聚脂肪酸 Dimer fatty acid

在本發明之含義內,該等二聚脂肪酸具有至少28個碳原子(C atoms)。其係藉由不飽和一元羧酸(monocarboxylic acids)之二聚合(dimerization)為二羧酸(dicarboxylic acids)而獲得,其中該二聚合較佳係藉由催化方式進行。根據本發明之該等二聚脂肪酸為二羧酸。該等二聚脂肪酸較佳為部分飽和,以及特別較佳其為完全飽和。 Within the meaning of the present invention, the dimerized fatty acids have at least 28 carbon atoms (C atoms). It is obtained by dimerization of unsaturated monocarboxylic acids to dicarboxylic acids, wherein the dimerization is preferably carried out by catalytic means. The dimerized fatty acids according to the present invention are dicarboxylic acids. The dimerized fatty acids are preferably partially saturated, and particularly preferably they are fully saturated.

該等單體之數量資訊 Quantity information of these monomers

如果該等聚醯胺(A)或(B)僅包含二酸和二胺,則其莫耳分率加起來,對所有二胺之總和為50mol%,對所有二酸之總和為50mol%,並且對該聚醯胺而言,該等二胺和二酸之分率之總和加起來為100mol%。 If the polyamides (A) or (B) only contain diacids and diamines, their molar fractions add up, the sum of all diamines is 50mol%, and the sum of all diacids is 50mol%, And for the polyamide, the sum of the fractions of the diamines and diacids add up to 100 mol%.

如果該等聚醯胺(A)或(B),除了二酸和二胺外,亦包括x mol%之內醯胺(lactams)或ω-胺基酸(ω-amino acids),則以100mol%之聚醯胺為基準,所有二胺之總和僅為(50-0.5x)mol%,以及所有二酸之總和僅為(50-0.5x)mol%。 If the polyamides (A) or (B), in addition to diacids and diamines, also include x mol% of lactams or ω-amino acids, then use 100mol % Of polyamide is the benchmark, the sum of all diamines is only (50-0.5x) mol%, and the sum of all diacids is only (50-0.5x) mol%.

關於該等聚醯胺之二酸和二胺之數量資訊,其始終適用於所有二胺之莫耳分率(molar fractions)之總和等於所有二酸之莫耳分率之總和。 Regarding the quantity information of the diacids and diamines of the polyamides, it is always applicable to the sum of molar fractions of all diamines equal to the sum of molar fractions of all diacids.

關於數量資訊之一般資訊 General information about quantity information

根據本發明之模制化合物較佳為包括成分(A)、(B)以及任選 之(C)及/或(D)及/或(E),在該過程中,適用之附帶條件為成分(A)、(B)以及任選之(C)及/或(D)及/或(E)之總和加起來為100wt.%。對個別成分(A)、(B)、(C)、(D)及(E)之數量資訊之既定範圍應理解為,在預定範圍內,可以為個別成分中之每一者選擇任意數量,只要滿足嚴格之附帶條件,即成分(A)、(B)及任選之(C)及/或(D)及/或(E)之總和為100wt.%。 The molding compound according to the present invention preferably includes ingredients (A), (B) and optionally (C) and/or (D) and/or (E). In the process, the applicable additional conditions are ingredients (A), (B) and optional (C) and/or (D) and/ Or the sum of (E) adds up to 100wt.%. The predetermined range of the quantity information of the individual components (A), (B), (C), (D) and (E) should be understood as, within the predetermined range, any quantity can be selected for each of the individual components, As long as the strict conditions are met, the total of ingredients (A), (B) and optional (C) and/or (D) and/or (E) is 100wt.%.

次氯酸(Hypochlorous Acid)、次氯酸鹽(Hypochlorite) Hypochlorous Acid, Hypochlorite

在本發明之含義內,就水溶液或耐受性而言,此兩個術語為同義詞,因為在水溶液中,這兩個種類之間存在平衡狀態。 Within the meaning of the present invention, in terms of aqueous solution or tolerance, these two terms are synonymous, because in an aqueous solution, there is an equilibrium state between these two species.

次氯酸和次氯酸鹽之間之此種平衡狀態是取決於pH值(參見水消毒副產品之形成動力學(Bildungskinetik von Wasserdesinfektionsnebenprodukten)-蒂姆.施洛瑟(Tim Schlosser)之論文,海德堡(Heidelberg)2018,第36至37頁),以及在pH值為6.8時,是在次氯酸一側。根據DIN 19643(游泳池和浴槽之水之處理)(在上述引文中(loc cit),圖2.5,第37頁),從哈格圖(Hägg diagram)中,就相關之pH值範圍6.5

Figure 109145569-A0202-12-0006-10
pH
Figure 109145569-A0202-12-0006-11
7.8而言,可以得出pH值為6.8時,約80%之次氯酸和約20%之次氯酸鹽之成分。 This equilibrium state between hypochlorous acid and hypochlorite is dependent on the pH value (see Bildungskinetik von Wasserdesinfektionsnebenprodukten)-Paper by Tim Schlosser, Heidelberg ( Heidelberg) 2018, pages 36 to 37), and at a pH of 6.8, on the hypochlorous acid side. According to DIN 19643 (treatment of water in swimming pools and baths) (in the above quotation (loc cit), Figure 2.5, page 37), from the Hägg diagram, the relevant pH range is 6.5
Figure 109145569-A0202-12-0006-10
pH
Figure 109145569-A0202-12-0006-11
In terms of 7.8, it can be concluded that when the pH is 6.8, about 80% of hypochlorous acid and about 20% of hypochlorite are composed.

含次氯酸鹽之溶液 Solution containing hypochlorite

在本發明之含義內,術語「含次氯酸鹽之溶液」包括次氯酸鹽離子(hypochlorite ions)(例如次氯酸鈉或次氯酸之溶液)在水中之溶液,以及因此包括次氯酸和次氯酸鹽之混合物,其中其濃度比係取決於pH值。 Within the meaning of the present invention, the term "hypochlorite-containing solution" includes solutions of hypochlorite ions (such as solutions of sodium hypochlorite or hypochlorous acid) in water, and therefore includes hypochlorous acid and hypochlorite. A mixture of chlorates, the concentration ratio of which depends on the pH value.

次氯酸鹽儲存 Hypochlorite storage

在本發明之含義範圍內,術語「次氯酸鹽儲存」包括將試樣(test specimens)(拉伸棒(tensile bars))儲存在次氯酸鹽離子(例如次氯酸鈉或 次氯酸之溶液)之水溶液中,以及因此儲存在次氯酸和次氯酸鹽之混合物中,其中其濃度比係取決於pH值。 Within the meaning of the present invention, the term "hypochlorite storage" includes storing test specimens (tensile bars) in hypochlorite ions (such as sodium hypochlorite or A solution of hypochlorous acid) in an aqueous solution, and therefore stored in a mixture of hypochlorous acid and hypochlorite, where the concentration ratio depends on the pH value.

因此,本發明涉及聚醯胺模制化合物之用途,該聚醯胺模制化合物包括或由以下所組成:至少一半結晶聚醯胺(A);以及至少一非晶質或微晶聚醯胺(B)用於生產對包含次氯酸及/或其鹽類之水溶液具耐受性之模製體。 Therefore, the present invention relates to the use of a polyamide molding compound, which comprises or consists of: at least half of crystalline polyamide (A); and at least one amorphous or microcrystalline polyamide (B) Used to produce molded bodies that are resistant to aqueous solutions containing hypochlorous acid and/or its salts.

耐受性係意指,以如第21頁所述內容測量,於儲存8064小時後,儲存之模製體之重量變化為不大於12%,較佳為不大於11%,以及特別較佳為不大於10%,及/或以如第21頁所述內容測量,於儲存8064小時後,存儲之模製體之拉伸力(tensile force)為未經存儲之試樣之拉伸力之值之至少70%,較佳為至少73%,以及特別較佳為至少75%。 Tolerability means that the weight change of the stored molded body after 8064 hours of storage is no more than 12%, preferably no more than 11%, and particularly preferably no more than 11%, measured as described on page 21 Not more than 10%, and/or measured as described on page 21, after 8064 hours of storage, the tensile force of the stored molded body is the value of the tensile force of the unstored sample It is at least 70%, preferably at least 73%, and particularly preferably at least 75%.

令人驚訝者為,在尋找能夠實現上述標的之合適之聚醯胺之過程中,得知申請專利範圍第1項所述之聚醯胺模制化合物對含有次氯酸鹽之溶液具有高耐受性,並且因此適合於根據本發明之目的。 Surprisingly, in the process of searching for a suitable polyamide to achieve the above-mentioned target, it was learned that the polyamide molding compound described in item 1 of the patent application has high resistance to solutions containing hypochlorite. Receptive and therefore suitable for the purpose according to the invention.

因此,根據本發明之用途,較佳為使其能夠生產出對包含次氯酸及/或其鹽類之水溶液具有耐受性之模製體。 Therefore, according to the application of the present invention, it is preferable to make it possible to produce a molded body that is resistant to an aqueous solution containing hypochlorous acid and/or its salt.

根據本發明之用途之較佳實施例,為提供生產模製體之用途,該模製體係選自於下列所組成之群組:用於輸送及/或儲存飲用水或溫水之部件;游泳池、漩渦池(whirlpools)、加熱系統中或衛生區(廚房、浴槽、 蒸氣浴(sauna)、盥洗室(toilet))中之部件;水龍頭;配件;外殼;混合器;分接頭(taps);過濾器外殼;水錶;水錶部件(軸承、螺桿(screw)、基座(pedestal));閥;閥部件(外殼、停止球(shut-off ball)、閘門(gate)、圓柱體(cylinders));分配器;濾罐(cartridges);泵;泵部件(動葉輪(impellers);觀察眼鏡(viewing glasses);蓋子;管線或容器(receptacles),以及其部件或元件。 According to a preferred embodiment of the use of the present invention, in order to provide the use of producing molded bodies, the molding system is selected from the group consisting of: parts for transporting and/or storing drinking or warm water; swimming pools , Whirlpools, heating systems or sanitary areas (kitchens, baths, Steam bath (sauna), toilet (toilet) components; faucet; accessories; housing; mixer; taps (taps); filter housing; water meter; water meter components (bearing, screw (screw), base ( pedestal)); valve; valve parts (housing, stop-off ball, gate, cylinders); distributor; cartridges; pumps; pump parts (impellers) ); viewing glasses (viewing glasses); lids; pipelines or containers (receptacles), and their parts or elements.

關於根據本發明之用途,可以規定,該聚醯胺模制化合物至少另外包含至少一無機填料(C)及/或任選地,至少一添加劑(D),及/或任選地,至少一不同於聚醯胺(A)、聚醯胺(B)和不同於添加劑(D)之進一步之聚合物(E)。 Regarding the use according to the present invention, it can be provided that the polyamide molding compound at least additionally contains at least one inorganic filler (C) and/or optionally, at least one additive (D), and/or optionally, at least one Different from polyamide (A), polyamide (B) and further polymer (E) different from additive (D).

在根據本發明之用途之一特別較佳之實施方案中,該聚醯胺模制化合物具有以下成分:19至95wt.%,較佳為25至89.39wt.%,特別較佳為21至67.9wt.%之至少一半結晶聚醯胺(A);5至60wt.%,較佳為10至50wt.%,特別較佳為15至30wt.%之至少一非晶質或微晶聚醯胺(B);0至70wt.%,較佳為0.1至60wt.%,特別較佳為15至50wt.%之至少一無機填料(C);0至6wt.%,較佳為0.01至5wt.%,以及特別較佳為0.1至4wt.%之至少一添加劑(D);以及0至20wt.%,較佳為0.5至15wt.%,以及特別較佳為2至10wt.%之至少一聚合物(E), 成分(A)至(E)加總為100wt.%。 In a particularly preferred embodiment of the use according to the present invention, the polyamide molding compound has the following composition: 19 to 95 wt.%, preferably 25 to 89.39 wt.%, particularly preferably 21 to 67.9 wt.% % Of at least half of the crystalline polyamide (A); 5 to 60wt.%, preferably 10 to 50wt.%, particularly preferably 15 to 30wt.% of at least one amorphous or microcrystalline polyamide ( B); 0 to 70wt.%, preferably 0.1 to 60wt.%, particularly preferably 15 to 50wt.% of at least one inorganic filler (C); 0 to 6wt.%, preferably 0.01 to 5wt.% , And particularly preferably at least one additive (D) of 0.1 to 4 wt.%; and at least one polymer of 0 to 20 wt.%, preferably 0.5 to 15 wt.%, and particularly preferably 2 to 10 wt.% (E), Ingredients (A) to (E) add up to 100wt.%.

在根據本發明之另一用途中,可以規定:該聚醯胺模制化合物至少另外包含至少一無機填料(C)及/或,任選地,至少一添加劑(D)。 In another use according to the present invention, it can be provided that the polyamide molding compound at least additionally contains at least one inorganic filler (C) and/or, optionally, at least one additive (D).

在根據本發明之用途之另一個特別較佳之實施方案中,該聚醯胺模制化合物具有以下成分:19至95wt.%,較佳為25至89.89wt.%,特別較佳為31至69.9wt.%之至少一半結晶聚醯胺(A);5至60wt.%,較佳為10至50wt.%,特別較佳為15至30wt.%之至少一非晶質或微晶聚醯胺(B);0至70wt.%,較佳為0.1至60wt.%,特別較佳為15至50wt.%之至少一無機填料(C);以及0至6wt.%,較佳為0.01至5wt.%,特別較佳為0.1至4wt.%之至少一添加劑(D);成分(A)至(D)加總為100wt.%。 In another particularly preferred embodiment of the use according to the present invention, the polyamide molding compound has the following composition: 19 to 95 wt.%, preferably 25 to 89.89 wt.%, particularly preferably 31 to 69.9 wt.% of at least half of crystalline polyamide (A); 5 to 60 wt.%, preferably 10 to 50 wt.%, particularly preferably 15 to 30 wt.% of at least one amorphous or microcrystalline polyamide (B); 0 to 70wt.%, preferably 0.1 to 60wt.%, particularly preferably 15 to 50wt.% of at least one inorganic filler (C); and 0 to 6wt.%, preferably 0.01 to 5wt. %, particularly preferably 0.1 to 4wt.% of at least one additive (D); components (A) to (D) add up to 100wt.%.

成分(A)至(E)在下文中詳細說明。 The ingredients (A) to (E) are explained in detail below.

成分(A)Ingredients (A)

根據本發明之一較佳實施方案,該至少一半結晶聚醯胺(A),根據ISO 11537-3(2013)測量,具有一熔化溫度為120至350℃,較佳為175至330℃,特別較佳為280至325℃,及/或根據ISO 11537-3(2013)測量,熔合熱(heat of fusion)為至少30J/g,特別較佳為至少35J/g,最特別較佳為至少40J/g,及/或根據ASTM D 1003-13(2013),在厚度為2mm之板子上測量之透光率係小於 80%,較佳為小於70%,特別較佳為小於60%。 According to a preferred embodiment of the present invention, the at least half crystalline polyamide (A), measured according to ISO 11537-3 (2013), has a melting temperature of 120 to 350°C, preferably 175 to 330°C, especially Preferably it is 280 to 325°C, and/or measured according to ISO 11537-3 (2013), the heat of fusion is at least 30J/g, particularly preferably at least 35J/g, most particularly preferably at least 40J /g, and/or according to ASTM D 1003-13(2013), the light transmittance measured on a board with a thickness of 2mm is less than 80%, preferably less than 70%, particularly preferably less than 60%.

根據本發明之另一個較佳實施方案,該至少一半結晶聚醯胺(A)是由單體(a1)至(a2),以及任選之(a3)所形成: According to another preferred embodiment of the present invention, the at least half crystalline polyamide (A) is formed from monomers (a1) to (a2), and optionally (a3):

(a1)至少一二胺,其係選自於以下所組成之群組:1,4-丁二胺(1,4-butanediamine)、1,5-戊二胺(1,5-pentanediamine)、1,6-己二胺(1,6-hexanediamine)、1,8-辛二胺(1,8-octanediamine)、1,9-壬二胺(1,9-nonanediamine)、1,10-癸二胺(1,10-decanediamin)、1,12-十二烷二胺(1,12-dodecanediamine)、2-甲基-1,5-戊二胺(2-methyl-1,5-pentanediamine)、2-甲基-1,8-辛二胺(2-methyl-1,8-octanediamine)、雙(4-胺基-環己基)甲烷(bis(4-amino-cyclohexyl)methane)、雙(胺基甲基)環己烷(bis(aminomethyl)cyclohexane)、異佛爾酮二胺(isophoronediamine)和間苯二甲胺(m-xylylenediamine);以及 (a1) At least one diamine, which is selected from the group consisting of 1,4-butanediamine (1,4-butanediamine), 1,5-pentanediamine (1,5-pentanediamine), 1,6-hexanediamine (1,6-hexanediamine), 1,8-octanediamine (1,8-octanediamine), 1,9-nonanediamine (1,9-nonanediamine), 1,10-decane Diamine (1,10-decanediamin), 1,12-dodecanediamine (1,12-dodecanediamine), 2-methyl-1,5-pentanediamine (2-methyl-1,5-pentanediamine) , 2-methyl-1,8-octanediamine (2-methyl-1,8-octanediamine), bis(4-amino-cyclohexyl)methane (bis(4-amino-cyclohexyl)methane), bis(4-amino-cyclohexyl)methane, bis(4-amino-cyclohexyl)methane, Bis(aminomethyl)cyclohexane, isophoronediamine and m-xylylenediamine; and

(a2)至少一二羧酸,其係選自於以下所組成之群組:1,6-己二酸(1,6-hexanedioic acid)、1,9-壬二酸(1,9-nonanedioic acid)、1,10-癸二酸(1,10-decanedioic acid,)、1,12-十二烷二酸(1,12-dodecanedioic acid)、1,13-十三烷二酸、1,14-十四烷二酸(1,14-tetradecanedioic acid)、1,15-十五烷酸(1,15-pentadecanoic acid)、1,16-十六烷二酸(1,16-hexadecanedioic acid)、1,17-十七烷二酸(1,17-heptadecanedioic acid)、1,18-十八烷二酸(1,18-octadecanedioic acid)、環己烷二羧酸(cyclohexanedicarboxylic acid)、具有36或44個碳原子之二聚脂肪酸、間苯二甲酸(isophthalic acid)和對苯二甲酸(terephthalic acid),及/或 (a2) At least one dicarboxylic acid, which is selected from the group consisting of 1,6-hexanedioic acid (1,6-hexanedioic acid), 1,9-nonanedioic acid (1,9-nonanedioic acid) acid), 1,10-decanedioic acid (1,10-decanedioic acid,), 1,12-dodecanedioic acid (1,12-dodecanedioic acid), 1,13-tridecanedioic acid, 1, 14-tetradecanedioic acid (1,14-tetradecanedioic acid), 1,15-pentadecanoic acid (1,15-pentadecanoic acid), 1,16-hexadecanedioic acid (1,16-hexadecanedioic acid) , 1,17-heptadecanedioic acid (1,17-heptadecanedioic acid), 1,18-octadecanedioic acid (1,18-octadecanedioic acid), cyclohexanedicarboxylic acid (cyclohexanedicarboxylic acid), with 36 Or 44-carbon dimerized fatty acid, isophthalic acid and terephthalic acid, and/or

(a3)一或多種內醯胺(lactams)或ω-胺基酸(ω-amino acids),其係選自於以下 所組成之群組:內醯胺-6(lactam-6)、內醯胺-11(lactam-11)、內醯胺-12(lactam-12)、1,6-胺基己酸(1,6-aminohexanoic acid)、1,11-胺基十一酸(1,11-aminoundecanoic acid)和1,12-胺基十二酸(1,12-aminododecanoic acid)。 (a3) One or more lactams or ω-amino acids, which are selected from the following The group consisting of: lactam-6 (lactam-6), lactam-11 (lactam-11), lactam-12 (lactam-12), 1,6-aminocaproic acid (1, 6-aminohexanoic acid), 1,11-aminoundecanoic acid (1,11-aminoundecanoic acid) and 1,12-aminododecanoic acid (1,12-aminododecanoic acid).

根據本發明之一特別較佳之實施方案,該至少一半結晶聚醯胺(A)係選自以下所組成之群組:PA 6、PA 46、PA 49、PA 410、PA 411、PA 412、PA 413、PA 414、PA 415、PA 416、PA 417、PA 418、PA 436、PA 56、PA 510、PA 66、PA 69、PA 610、PA 611、PA 612、PA 613、PA 614、PA 615、PA 616、PA 617、PA 618、PA 1010、PA 66/6、PA 6/66/610、PA 6/66/12、PA 6/12、PA 11、PA 12、PA 912、PA 1212、PA MXD6、PA MXD9、PA MXD10、PA MXD11、PA MXD12、PA MXD13、PA MXD14、PA MXD15、PA MXD16、PA MXD17、PA MXD18、PA MXD36、PA MXD6/MXDI、具有4T重複單元(4T repeating unit)之聚醯胺、具有5T重複單元之聚醯胺、具有6T重複單元之聚醯胺、具有8T重複單元之聚醯胺、具有9T重複單元之聚醯胺、具有10T重複單元之聚醯胺、具有12T重複單元之聚醯胺、PA 4T/6T、PA 4T/8T、PA 6T/8T、PA 4T/MPMDT、PA 4T/4I、PA 5T/5I、PA 6T/6I、PA 9T/MODT、PA 9T/9I、PA 10T、PA 10T/6T、PA 10T/6T/10I/6I、PA 12T、PA MPMDT/6T、PA 10T/10I、PA 12T/12I、PA 4T/6T/8T、PA 4T/6T/10T、PA 4T/8T/10T、PA6T/8T/10T、PA 4T/6T/MPMDT、PA 6T/6、PA 6T/66、PA 4T/66、PA 5T/66、PA 6T/6I/6、PA 10T/6T/1012/612、PA 6T/BACT、PA 6I/6T/BACI/BACT、PA 66/BAC6/MACM6、PA 66/BAC6/PACM6、PA 66/BAC6/IPD6,及其混合物或共聚物,較佳為 PA 6、PA 66、PA 69、PA 610、PA 612、PA 616、PA 1010、PA 66/6、PA 6/12、PA 11、PA 12、PA 1212、PA MXD6、PA MXD10、PA 6T/6I、PA 9T/MODT、PA 10T、PA 10T/6T、PA 10T/6T/10I/6I、PA 12T、PA 10T/10I、PA 6T/6、PA 6T/66、PA 10T/6T/1012/612、PA 6T/BACT、PA 6I/6T/BACI/BACT、PA 66/BAC6/MACM6、PA 66/BAC6/PACM6、PA 66/BAC6/IPD6,特別較佳為PA 6、PA 66、PA 610、PA 612、PA 616、PA 1010、PA 66/6、PA 6/12、PA 12、PA 6T/6I、PA 10T、PA 10T/6T、PA 10T/6T/10I/6I、PA 10T/10I、PA 6T/6、PA 6T/66、PA 6T/6I/6、PA 10T/6T/1012/612、PA 6T/BACT、PA 6I/6T/BACI/BACT、PA 66/BAC6/MACM6。 According to a particularly preferred embodiment of the present invention, the at least half crystalline polyamide (A) is selected from the group consisting of: PA 6, PA 46, PA 49, PA 410, PA 411, PA 412, PA 413, PA 414, PA 415, PA 416, PA 417, PA 418, PA 436, PA 56, PA 510, PA 66, PA 69, PA 610, PA 611, PA 612, PA 613, PA 614, PA 615, PA 616, PA 617, PA 618, PA 1010, PA 66/6, PA 6/66/610, PA 6/66/12, PA 6/12, PA 11, PA 12, PA 912, PA 1212, PA MXD6 , PA MXD9, PA MXD10, PA MXD11, PA MXD12, PA MXD13, PA MXD14, PA MXD15, PA MXD16, PA MXD17, PA MXD18, PA MXD36, PA MXD6/MXDI, with 4T repeating unit (4T repeating unit) Amide, polyamide with 5T repeating unit, polyamide with 6T repeating unit, polyamide with 8T repeating unit, polyamide with 9T repeating unit, polyamide with 10T repeating unit, with 12T Repeating units of polyamide, PA 4T/6T, PA 4T/8T, PA 6T/8T, PA 4T/MPMDT, PA 4T/4I, PA 5T/5I, PA 6T/6I, PA 9T/MODT, PA 9T/ 9I, PA 10T, PA 10T/6T, PA 10T/6T/10I/6I, PA 12T, PA MPMDT/6T, PA 10T/10I, PA 12T/12I, PA 4T/6T/8T, PA 4T/6T/10T , PA 4T/8T/10T, PA6T/8T/10T, PA 4T/6T/MPMDT, PA 6T/6, PA 6T/66, PA 4T/66, PA 5T/66, PA 6T/6I/6, PA 10T /6T/1012/612, PA 6T/BACT, PA 6I/6T/BACI/BACT, PA 66/BAC6/MACM6, PA 66/BAC6/PACM6, PA 66/BAC6/IPD6, and their mixtures or copolymers, more Jiawei PA 6, PA 66, PA 69, PA 610, PA 612, PA 616, PA 1010, PA 66/6, PA 6/12, PA 11, PA 12, PA 1212, PA MXD6, PA MXD10, PA 6T/6I , PA 9T/MODT, PA 10T, PA 10T/6T, PA 10T/6T/10I/6I, PA 12T, PA 10T/10I, PA 6T/6, PA 6T/66, PA 10T/6T/1012/612, PA 6T/BACT, PA 6I/6T/BACI/BACT, PA 66/BAC6/MACM6, PA 66/BAC6/PACM6, PA 66/BAC6/IPD6, particularly preferably PA 6, PA 66, PA 610, PA 612 , PA 616, PA 1010, PA 66/6, PA 6/12, PA 12, PA 6T/6I, PA 10T, PA 10T/6T, PA 10T/6T/10I/6I, PA 10T/10I, PA 6T/ 6. PA 6T/66, PA 6T/6I/6, PA 10T/6T/1012/612, PA 6T/BACT, PA 6I/6T/BACI/BACT, PA 66/BAC6/MACM6.

該半結晶聚醯胺(A)之相對黏度,根據ISO 307(2013)在20℃下,測定0.5克聚醯胺在100ml間甲酚(m-cresol)中之溶液,其較佳為1.40至2.50,特別較佳為1.45至2.30,以及最特別較佳為1.60至2.15。 The relative viscosity of the semi-crystalline polyamide (A) is measured in accordance with ISO 307 (2013) at 20° C., a solution of 0.5 g of polyamide in 100 ml of m-cresol (m-cresol), which is preferably 1.40 to 2.50, particularly preferably 1.45 to 2.30, and most particularly preferably 1.60 to 2.15.

成分(B)Ingredients (B)

根據本發明之一較佳實施方案,該至少一非晶質或半結晶聚醯胺(B)根據ISO 11537-3(2013)測量,具有熔合熱為不大於28J/g,特別較佳為不大於25J/g,最特別較佳為不大於0至23J/g,及/或根據ASTM D 1003-13(2013),在厚度為2mm之板子上測得之透光率為至少80%,較佳為至少85%,特別較佳為至少90%,及/或根據ISO 11537-2(2013)測量之玻璃轉換溫度為60至240℃,較佳為80至230℃,特別較佳為105至210℃。 According to a preferred embodiment of the present invention, the at least one amorphous or semi-crystalline polyamide (B) is measured according to ISO 11537-3 (2013) and has a heat of fusion of not more than 28J/g, particularly preferably not More than 25J/g, most particularly preferably not more than 0 to 23J/g, and/or according to ASTM D 1003-13 (2013), the light transmittance measured on a board with a thickness of 2mm is at least 80%, which is more It is preferably at least 85%, particularly preferably at least 90%, and/or the glass transition temperature measured according to ISO 11537-2 (2013) is 60 to 240°C, preferably 80 to 230°C, particularly preferably 105 to 210°C.

根據本發明之另一較佳實施方案,該至少一非晶質或微晶聚醯胺(B)係由單體(b1)至(b2),以及任選之(b3)所形成: According to another preferred embodiment of the present invention, the at least one amorphous or microcrystalline polyamide (B) is formed from monomers (b1) to (b2), and optionally (b3):

(b1)至少一二胺,其係選自於以下所組成之群組:1,6-己二胺(1,6-hexanediamine)、1,10-癸二胺(1,10-decanediamine)、1,12-十二烷二胺(1,12-dodecanediamine)、2-甲基-1,5-戊二胺(2-methyl-1,5-pentanediamine)、間苯二甲胺(m-xylylenediamine)、雙(4-胺基-3-甲基環己基)甲烷(bis(4-amino-3-methylcyclohexyl)methane)、雙(4-胺基環己基)甲烷(bis(4-aminocyclohexyl)methane)、雙(4-胺基-3,5-二甲基環己基)甲烷(bis(4-amino-3,5-dimethylcyclohexyl)methane)、作為2,2,4-三甲基六亞甲基二胺(2,2,4-trimethylhexamethylenediamine)之雙(胺基甲基)環己烷ND(bis(aminomethyl)cyclohexane ND)、以及作為2,4,4-三甲基六亞甲基二胺(2,4,4-trimethylhexamethylenediamin)之IND,以及 (b1) At least one diamine, which is selected from the group consisting of 1,6-hexanediamine (1,6-hexanediamine), 1,10-decanediamine (1,10-decanediamine), 1,12-dodecanediamine (1,12-dodecanediamine), 2-methyl-1,5-pentanediamine (2-methyl-1,5-pentanediamine), m-xylylenediamine ), bis(4-amino-3-methylcyclohexyl)methane, bis(4-aminocyclohexyl)methane , Bis(4-amino-3,5-dimethylcyclohexyl)methane (bis(4-amino-3,5-dimethylcyclohexyl)methane), as 2,2,4-trimethylhexamethylene bis Amine (2,2,4-trimethylhexamethylenediamine) bis(aminomethyl)cyclohexane ND (bis(aminomethyl)cyclohexane ND), and as 2,4,4-trimethylhexamethylenediamine (2 ,4,4-trimethylhexamethylenediamin) IND, and

(b2)至少一二羧酸,其係選自於以下所組成之群組:1,6-己二酸(1,6-hexanedioic acid)、1,10-癸二酸(1,10-decanedioic acid)、1,12-十二烷二酸(1,12-dodecanedioic acid)、1,14-十四烷二酸(1,14-tetradecanedioic acid)、1,16-十六烷二酸(1,16-hexadecanedioic acid)、1,18-十八烷二酸(1,18-octadecanedioic acid)、具有36或44個碳原子之二聚脂肪酸、環己烷二羧酸(cyclohexanedicarboxylic acid)、間苯二甲酸、對苯二甲酸和萘二甲酸(naphthalenedicarboxylic acid);及/或 (b2) At least one dicarboxylic acid, which is selected from the group consisting of: 1,6-hexanedioic acid (1,6-hexanedioic acid), 1,10-decanedioic acid (1,10-decanedioic acid) acid), 1,12-dodecanedioic acid (1,12-dodecanedioic acid), 1,14-tetradecanedioic acid (1,14-tetradecanedioic acid), 1,16-hexadecanedioic acid (1 ,16-hexadecanedioic acid), 1,18-octadecanedioic acid (1,18-octadecanedioic acid), dimerized fatty acids with 36 or 44 carbon atoms, cyclohexanedicarboxylic acid, isobenzene Dicarboxylic acid, terephthalic acid and naphthalenedicarboxylic acid; and/or

(b3)一或多種內醯胺或ω-胺基酸,其係選自於以下所組成之群組:內醯胺-6、內醯胺-11、內醯胺-12、1,6-胺基己酸、1,11-胺基十一酸和1,12-胺基十二酸。 (b3) One or more endoamides or ω-amino acids, which are selected from the group consisting of endoamide-6, endoamide-11, endoamide-12, 1,6- Aminocaproic acid, 1,11-aminoundecanoic acid and 1,12-aminododecanoic acid.

根據本發明之一特別較佳之實施方案,該至少一非晶質或微晶聚醯胺(B)係選自於以下所組成之群組:PA 6I、PA 6I/6T、PA 10I/10T、PA MPMDI/MPMDT、PA 6I/6T/6N、PA MXDI/6I、PA MXDI/MXDT/6I/6T、PA MXDI/12I、PA MXDI、PA MXDI/MXD6、PA MACM10、PA MACM12、PA MACM14、PA MACM16、PA MACM18、PA NDT/INDT、PA TMDC10、PA TMDC12、PA TMDC14、PA TMDC16、PA TMDC18、PA PACM12、PA PACM14、PA PACM16、PA PACM18、PA PACM10/11、PA PACM10/12、PA PACM12/612、PA PACM12/PACM14/612/614、PA MACMI/12、PA MACMT/12、PA MACMI/MACM12、PA MACMI/MACMN、PA MACMT/MACM12、PA MACMT/MACMN、PA MACM36、PA TMDC36、PA MACMI/MACM36、PA 6I/MACMI/12、PA MACMT/MACM36、PA MACMI/MACMT/MACM36、PA MACMI/MACMT/12、PA 6I/6T/MACMI/MACMT、PA 6I/6T/MACMI/MACMT/12、PA MACM6/11、PA MACM6/12、PA MACM10/11、PA MACM10/12、PA MACM10/1010、PA MACM12/1012、PA MACM12/1212、PA MACM14/1014、PA MACM14/1214、PA MACM16/1016、PA MACM18/1018、PA 6I/6T/MACMI/MACMT/MACM12/612、PA 6I/6T/MACMI/MACMT/MACM12、PA MACMI/MACMT/MACM12/12、PA MACMI/MACMT/MACM12、PA 6I/6T/MACMI/MACMT/12、PA 6I/6T/6N/MACMI/MACMT/MACMN、PA TMDC12/TMDCT/TMDC36、PA TMDC12/TMDCI、PA TMDC12/TMDCI/TMDC36、PA TMDC12/TMDCT、 PA 6I/6T/BACI/BACT、PA MACMI/MACMT/BACI/BACT、PA 6I/6T/MACMI/MACMT/BACI/BACT、PA MACMI/MACMT/MACM12/MACM36、PA MACMI/MACMT/MACM14/MACM36、PA MACMI/MACMT/MACMCHD/MACM36、PA TMDCI/TMDCT/TMDC12/TMDC36、PA TMDCI/TMDCT/TMDC14/TMDC36、PA TMDCI/TMDCT/TMDCCHD/TMDC36,及其混合物或共聚物,其中基於100mol%之所有單體之莫耳分率(molar fractions)之總和,MACM可以被最多為35mol%之PACM及/或TMDC取代,及/或月桂脂內醯胺(laurin lactam)可以全部或部分地被己內醯胺(caprolactam)取代,及/或具有36個碳原子之二聚脂肪酸可以全部或部分地被具有44個碳原子之二聚脂肪酸取代,較佳為PA 6I/6T、PA 10I/10T、PA MPMDI/MPMDT、PA MXDI/6I、PA MXDI/MXDT/6I/6T、PA MACM10、PA MACM12、PA MACM14、PA MACM16、PA MACM18、PA NDT/INDT、PA TMDC10、PA TMDC12、PA TMDC14、PA TMDC16、PA TMDC18、PA PACM12、PA PACM14、PA PACM16、PA PACM18、PA PACM10/11、PA PACM10/12、PA PACM12/612、PA PACM12/PACM14/612/614、PA MACMI/12、PA MACMT/12、PA MACMI/MACM12、PA 6I/MACMI/12、PA MACMI/MACMT/12、PA 6I/6T/MACMI/MACMT、PA 6I/6T/MACMI/MACMT/12、PA MACM10/1010、PA MACM14/1014、PA 6I/6T/MACMI/MACMT/MACM12/612、PA MACMI/MACMT/MACM12、PA 6I/6T/MACMI/MACMT/12、PA TMDC12/TMDCI、PA TMDC12/TMDCI/TMDC36、PA 6I/6T/BACI/BACT、PA 6I/6T/MACMI/MACMT/BACI/BACT、PA MACMI/MACMT/MACM12/MACM36、PA MACMI/MACMT/MACM14/MACM36、PA MACMI/MACMT/MACMCHD/MACM36、PA TMDCI/TMDCT/TMDC12/TMDC36、PA TMDCI/TMDCT/TMDC14/TMDC36、PA TMDCI/TMDCT/TMDCCHD/TMDC36,以及其混合物或共聚物,其中基於100mol%之所有單體之莫耳分率之總和,MACM可以被最多為35mol%之PACM及/或TMDC取代,及/或月桂脂內醯胺可以全部或部分地被己內醯胺取代,及/或具有36個碳原子之二聚脂肪酸可以全部或部分地被具有44個碳原子之二聚脂肪酸取代,特別較佳為PA 6I/6T、PA 10I/10T、PA MXDI/6I、PA MACM10、PA MACM12、PA MACM14、PA MACM16、PA MACM18、PA TMDC10、PA TMDC12、PA TMDC14、PA TMDC16、PA TMDC18、PA PACM12、PA PACM14、PA PACM16、PA PACM18、PA PACM10/11、PA PACM10/12、PA PACM12/612、 PA PACM12/PACM14/612/614、PA MACMI/12、PA MACMT/12、PA MACMI/MACM12、PA 6I/MACMI/12、PA MACMI/MACMT/12、PA 6I/6T/MACMI/MACMT/MACM12/612、PA MACMI/MACMT/MACM12、PA 6I/6T/MACMI/MACMT/12、PA TMDC12/TMDCI、PA TMDC12/TMDCI/TMDC36、PA MACMI/MACMT/MACM12/MACM36、PA MACMI/MACMT/MACM14/MACM36、PA TMDCI/TMDCT/TMDC12/TMDC36、PA TMDCI/TMDCT/TMDC14/TMDC36,以及其混合物或共聚物,其中基於100mol%之所有單體之莫耳分率之總和,MACM可以被最多為35mol%之PACM及/或TMDC取代,及/或月桂脂內醯胺可以全部或部分地被己內醯胺取代,及/或具有36個碳原子之二聚脂肪酸可以全部或部分地被具有44個碳原子之二聚脂肪酸取代。 According to a particularly preferred embodiment of the present invention, the at least one amorphous or microcrystalline polyamide (B) is selected from the group consisting of: PA 6I, PA 6I/6T, PA 10I/10T, PA MPMDI/MPMDT, PA 6I/6T/6N, PA MXDI/6I, PA MXDI/MXDT/6I/6T, PA MXDI/12I, PA MXDI, PA MXDI/MXD6, PA MACM10, PA MACM12, PA MACM14, PA MACM16 , PA MACM18, PA NDT/INDT, PA TMDC10, PA TMDC12, PA TMDC14, PA TMDC16, PA TMDC18, PA PACM12, PA PACM14, PA PACM16, PA PACM18, PA PACM10/11, PA PACM10/12, PA PACM12/612 , PA PACM12/PACM14/612/614, PA MACMI/12, PA MACMT/12, PA MACMI/MACM12, PA MACMI/MACMN, PA MACMT/MACM12, PA MACMT/MACMN, PA MACM36, PA TMDC36, PA MACMI/MACM36 , PA 6I/MACMI/12, PA MACMT/MACM36, PA MACMI/MACMT/MACM36, PA MACMI/MACMT/12, PA 6I/6T/MACMI/MACMT, PA 6I/6T/MACMI/MACMT/12, PA MACM6/ 11.PA MACM6/12, PA MACM10/11, PA MACM10/12, PA MACM10/1010, PA MACM12/1012, PA MACM12/1212, PA MACM14/1014, PA MACM14/1214, PA MACM16/1016, PA MACM18/ 1018, PA 6I/6T/MACMI/MACMT/MACM12/612, PA 6I/6T/MACMI/MACMT/MACM12, PA MACMI/MACMT/MACM12/12, PA MACMI/MACMT/MACM12, PA 6I/6T/MACMI/MACMT /12, PA 6I/6T/6N/MACMI/MACMT/MACMN, PA TMDC12/TMDCT/TMDC36, PA TMDC12/TMDCI, PA TMDC12/TMDCI/TMDC36, PA TM DC12/TMDCT, PA 6I/6T/BACI/BACT, PA MACMI/MACMT/BACI/BACT, PA 6I/6T/MACMI/MACMT/BACI/BACT, PA MACMI/MACMT/MACM12/MACM36, PA MACMI/MACMT/MACM14/MACM36, PA MACMI/MACMT/MACMCHD/MACM36, PA TMDCI/TMDCT/TMDC12/TMDC36, PA TMDCI/TMDCT/TMDC14/TMDC36, PA TMDCI/TMDCT/TMDCCHD/TMDC36, and mixtures or copolymers thereof, based on 100mol% of all monomers The sum of molar fractions, MACM can be replaced by PACM and/or TMDC up to 35 mol%, and/or laurin lactam can be fully or partially replaced by caprolactam ( caprolactam) substitution, and/or the dimer fatty acid with 36 carbon atoms can be fully or partially substituted by the dimer fatty acid with 44 carbon atoms, preferably PA 6I/6T, PA 10I/10T, PA MPMDI/MPMDT , PA MXDI/6I, PA MXDI/MXDT/6I/6T, PA MACM10, PA MACM12, PA MACM14, PA MACM16, PA MACM18, PA NDT/INDT, PA TMDC10, PA TMDC12, PA TMDC14, PA TMDC16, PA TMDC18, PA PACM12, PA PACM14, PA PACM16, PA PACM18, PA PACM10/11, PA PACM10/12, PA PACM12/612, PA PACM12/PACM14/612/614, PA MACMI/12, PA MACMT/12, PA MACMI/MACM12 , PA 6I/MACMI/12, PA MACMI/MACMT/12, PA 6I/6T/MACMI/MACMT, PA 6I/6T/MACMI/MACMT/12, PA MACM10/1010, PA MACM14/1014, PA 6I/6T/MACMI/MACMT/MACM12/612, PA MACMI/MACMT/MACM12, PA 6I/6T/MACMI/MACMT/12, PA TMDC12/TMDCI, PA TMDC12/TMDCI/TMDC36, PA 6I/6T/BACI/BACT, PA 6I/6T/MACMI/MACMT/BACI/BACT, PA MACMI/MACMT/MACM12 /MACM36, PA MACMI/MACMT/MACM14/MACM36, PA MACMI/MACMT/MACMCHD/MACM36, PA TMDCI/TMDCT/TMDC12/TMDC36, PA TMDCI/TMDCT/TMDC14/TMDC36, PA TMDCI/TMDCT/TMDCCHD/TMDC36, and others Mixtures or copolymers, in which, based on 100 mol% of the sum of the molar fractions of all monomers, MACM can be substituted with up to 35 mol% of PACM and/or TMDC, and/or lauryl lactam can be wholly or partly substituted Caprolactam substitution, and/or the dimer fatty acid with 36 carbon atoms can be fully or partially substituted by the dimer fatty acid with 44 carbon atoms, particularly preferably PA 6I/6T, PA 10I/10T, PA MXDI/6I, PA MACM10, PA MACM12, PA MACM14, PA MACM16, PA MACM18, PA TMDC10, PA TMDC12, PA TMDC14, PA TMDC16, PA TMDC18, PA PACM12, PA PACM14, PA PACM16, PA PACM18, PA PACM10/11 , PA PACM10/12, PA PACM12/612, PA PACM12/PACM14/612/614, PA MACMI/12, PA MACMT/12, PA MACMI/MACM12, PA 6I/MACMI/12, PA MACMI/MACMT/12, PA 6I/6T/MACMI/MACMT/MACM12/612 , PA MACMI/MACMT/MACM12, PA 6I/6T/MACMI/MACMT/12, PA TMDC12/TMDCI, PA TMDC12/TMDCI/TMDC36, PA MACMI/MACMT/MACM12/MACM36, PA MACMI/MACMT/MACM14/MACM36, PA TMDCI/TMDCT/TMDC12/TMDC36, PA TMDCI/TMDCT/TMDC14/TMDC36, and their mixtures or copolymers, wherein based on 100mol% of the sum of the molar fractions of all monomers, MACM can be up to 35mol% of PACM and / Or TMDC substitution, and/or lauryl lactam may be fully or partially substituted by caprolactam, and/or the dimer fatty acid with 36 carbon atoms may be fully or partially substituted with two of 44 carbon atoms Poly fatty acid substitution.

在該等非晶質聚醯胺PA 6I/6T、PA 10I/10T中,間苯二甲酸之含量較佳為53至90mol%,以及特別較佳為高達55至80mol%。最特別較佳為,間苯二甲酸與對苯二甲酸之莫耳比(mol ratio)為65:35至70:30。 In these amorphous polyamides PA 6I/6T and PA 10I/10T, the content of isophthalic acid is preferably 53 to 90 mol%, and particularly preferably up to 55 to 80 mol%. Most particularly preferably, the mol ratio of isophthalic acid to terephthalic acid is 65:35 to 70:30.

在非晶質PA MXDI/6I中,1,6-己二胺之含量較佳為15至40mol%,以及特別較佳為20至35mol%,其中所有單體之莫耳分率之總和為100mol%。尤其,較佳為PA MXDI/6I之莫耳比為46/54。 In the amorphous PA MXDI/6I, the content of 1,6-hexamethylene diamine is preferably 15 to 40 mol%, and particularly preferably 20 to 35 mol%, wherein the total molar fraction of all monomers is 100 mol %. In particular, it is preferable that the molar ratio of PA MXDI/6I is 46/54.

在PA PACM12/612中,1,6-己二胺之含量較佳為2至24mol%,以及特別較佳為6至15mol%,其中所有單體之莫耳分率之總和為100mol%。含有最多為24mol%之1,6-己二胺之聚醯胺PA PACM12/612為微晶 (microcrystalline)。 In PA PACM12/612, the content of 1,6-hexamethylene diamine is preferably 2 to 24 mol%, and particularly preferably 6 to 15 mol%, wherein the sum of the molar fractions of all monomers is 100 mol%. Polyamide PA PACM12/612 containing up to 24 mol% of 1,6-hexamethylene diamine is microcrystalline (microcrystalline).

在PA PACM12/PACM14/612/614中,1,6-己二胺之含量較佳為2至24mol%,以及特別較佳為6至15mol%,及/或1,14-十四烷二酸之含量為2至24mol%,以及較佳為6至15mol%,其中所有單體之莫耳分率之總和為100mol%。含有最大為24mol%之1,6-己二胺之聚醯胺PA PACM12/PACM14/612/614為微晶。 In PA PACM12/PACM14/612/614, the content of 1,6-hexamethylene diamine is preferably 2 to 24 mol%, and particularly preferably 6 to 15 mol%, and/or 1,14-tetradecanedioic acid The content is 2 to 24 mol%, and preferably 6 to 15 mol%, wherein the sum of the molar fractions of all monomers is 100 mol%. Polyamide PA PACM12/PACM14/612/614 containing up to 24mol% of 1,6-hexamethylenediamine is microcrystalline.

在非晶質PA MACMI/12中,月桂脂內醯胺之含量較佳為15至50mol%,特別較佳為20至40mol%,以及最特別較佳為19mol%或35mol%,其中所有單體之莫耳分率之總和為100mol%。 In the amorphous PA MACMI/12, the content of lauryl lactam is preferably 15 to 50 mol%, particularly preferably 20 to 40 mol%, and most particularly preferably 19 mol% or 35 mol%, in which all monomers The total mole fraction is 100mol%.

在非晶質PA MACMI/MACMT/12中,間苯二甲酸之含量較佳為等於對苯二甲酸之含量及/或月桂脂內醯胺之含量較佳為15至40mol%,以及特別較佳為20至30mol%,以及最特別較佳為重複單元MACMI/MACMT/12之莫耳比為38/38/24,其中所有單體之莫耳分率之總和為100mol%。 In the amorphous PA MACMI/MACMT/12, the content of isophthalic acid is preferably equal to the content of terephthalic acid and/or the content of lauryl lactam is preferably 15 to 40 mol%, and particularly preferably It is 20 to 30 mol%, and most particularly preferably the molar ratio of the repeating unit MACMI/MACMT/12 is 38/38/24, wherein the sum of the molar fractions of all monomers is 100 mol%.

在非晶質PA MACMI/MACMT/MAMC12中,間苯二甲酸之含量較佳為等於對苯二甲酸之含量及/或十二烷二酸之含量較佳為30至60mol%,以及特別較佳為40至50mol%,以及最特別較佳為重複單元MACMI/MACMT/MACM12之莫耳比為27/27/46,其中所有單體之莫耳分率之總和為100mol%。 In the amorphous PA MACMI/MACMT/MAMC12, the content of isophthalic acid is preferably equal to the content of terephthalic acid and/or the content of dodecanedioic acid is preferably 30 to 60 mol%, and particularly preferably It is 40 to 50 mol%, and most particularly preferably the molar ratio of the repeating unit MACMI/MACMT/MACM12 is 27/27/46, wherein the sum of the molar fractions of all monomers is 100 mol%.

在非晶質PA 6I/6T/MACMI/MACMT/12中,間苯二甲酸之含量較佳為等於對苯二甲酸之含量及/或月桂脂內醯胺之含量較佳為1至25mol%,以及特別較佳為2至15mol%,以及最特別較佳為重複單元 6I/6T/MACMI/MACMT/12之莫耳比為34/34/14/14/4或39/39/9.6/9.6/2.8,其中所有單體之莫耳分率之總和為100mol%。 In the amorphous PA 6I/6T/MACMI/MACMT/12, the content of isophthalic acid is preferably equal to the content of terephthalic acid and/or the content of lauryl lactam is preferably 1 to 25 mol%, And particularly preferably 2 to 15 mol%, and most particularly preferably repeating units The molar ratio of 6I/6T/MACMI/MACMT/12 is 34/34/14/14/4 or 39/39/9.6/9.6/2.8, and the sum of the molar fractions of all monomers is 100 mol%.

在聚醯胺PA MACM10/PACM10、PA MACM12/PACM12、PA MACM14/PACM14、PA MACM16/PACM16、PA MACM18/PACM18中,PACM之含量較佳為1至35mol%,以及特別較佳為2至25mol%,其中所有單體之莫耳分率之總和為100mol%。包含最大為25mol%PACM之聚醯胺PA MACM10/PACM10、PA MACM12/PACM12或PA MACM14/PACM14 PA MACM16/PACM16、PA MACM18/PACM18為非晶質(amorphous)。 In polyamide PA MACM10/PACM10, PA MACM12/PACM12, PA MACM14/PACM14, PA MACM16/PACM16, PA MACM18/PACM18, the content of PACM is preferably 1 to 35 mol%, and particularly preferably 2 to 25 mol% , Where the sum of the molar fractions of all monomers is 100 mol%. The polyamides PA MACM10/PACM10, PA MACM12/PACM12, or PA MACM14/PACM14 PA MACM16/PACM16, PA MACM18/PACM18 containing up to 25 mol% of PACM are amorphous.

在非晶質PA 6I/6T/MACMI/MACMT/PACMI/PACMT/12中,間苯二甲酸之含量較佳為等於對苯二甲酸之含量,及/或月桂脂內醯胺之含量較佳為2至15mol%,以及特別較佳為2至7mol%,及/或PACM之含量較佳為2至7mol%,其中所有單體之莫耳分率之總和為100mol%。 In the amorphous PA 6I/6T/MACMI/MACMT/PACMI/PACMT/12, the content of isophthalic acid is preferably equal to the content of terephthalic acid, and/or the content of lauryl lactam is preferably 2 to 15 mol%, and particularly preferably 2 to 7 mol%, and/or the content of PACM is preferably 2 to 7 mol%, wherein the sum of the molar fractions of all monomers is 100 mol%.

在非晶質聚醯胺PA MACMI/MACMT/MACM12/MACM36、PA MACMI/MACMT/MACM14/MACM36中,間苯二甲酸之莫耳分率較佳為至少等於對苯二甲酸之莫耳分率,以及間苯二甲酸之含量較佳為6至49.55mol%,特別較佳為7至43.5mol%,以及最特別較佳為11.5至27mol%,及/或對苯二甲酸之含量較佳為0.1至24.775mol%,特別較佳為0.5至22mol%,以及最特別較佳為11.5至19.25mol%,及/或1,12-十二烷二酸或1,14-十四烷二酸之含量較佳為0.1至37.75mol%,特別較佳為5至35mol%,以及最特別較佳為10至25.5mol%,及/或具有36個碳原子之二聚脂肪酸之含量較佳為0.25至10mol%,特別較佳為1至7.5mol%,以及最特別較佳為1.5至4.4 mol%。 In the amorphous polyamide PA MACMI/MACMT/MACM12/MACM36, PA MACMI/MACMT/MACM14/MACM36, the molar fraction of isophthalic acid is preferably at least equal to the molar fraction of terephthalic acid, And the content of isophthalic acid is preferably 6 to 49.55 mol%, particularly preferably 7 to 43.5 mol%, and most particularly preferably 11.5 to 27 mol%, and/or the content of terephthalic acid is preferably 0.1 To 24.775 mol%, particularly preferably 0.5 to 22 mol%, and most particularly preferably 11.5 to 19.25 mol%, and/or the content of 1,12-dodecanedioic acid or 1,14-tetradecanedioic acid Preferably it is 0.1 to 37.75 mol%, particularly preferably 5 to 35 mol%, and most particularly preferably 10 to 25.5 mol%, and/or the content of the dimer fatty acid having 36 carbon atoms is preferably 0.25 to 10 mol %, particularly preferably 1 to 7.5 mol%, and most particularly preferably 1.5 to 4.4 mol%.

在非晶質聚醯胺PA TMDCI/TMDCT/TMDC12/TMDC36、PA TMDCI/TMDCT/TMDC14/TMDC36中,間苯二甲酸之莫耳分率較佳為至少等於對苯二甲酸之莫耳分率,以及間苯二甲酸之含量較佳為6至49.55mol%,特別較佳為7至43.5mol%,以及最特別較佳為11.5至27mol%,及/或對苯二甲酸之含量較佳為0.1至24.775mol%,特別較佳為0.5至22mol%,以及最特別較佳為11.5至19.25mol%,及/或1,12-十二烷二酸或1,14-十四烷二酸之含量較佳為0.1至37.75mol%,特別較佳為5至35mol%,以及最特別較佳為10至25.5mol%,及/或具有36個碳原子之二聚脂肪酸之含量較佳為0.25至10mol%,特別較佳為1至7.5mol%,以及最特別較佳為1.5至4.4mol%。 In the amorphous polyamide PA TMDCI/TMDCT/TMDC12/TMDC36, PA TMDCI/TMDCT/TMDC14/TMDC36, the molar fraction of isophthalic acid is preferably at least equal to the molar fraction of terephthalic acid, And the content of isophthalic acid is preferably 6 to 49.55 mol%, particularly preferably 7 to 43.5 mol%, and most particularly preferably 11.5 to 27 mol%, and/or the content of terephthalic acid is preferably 0.1 To 24.775 mol%, particularly preferably 0.5 to 22 mol%, and most particularly preferably 11.5 to 19.25 mol%, and/or the content of 1,12-dodecanedioic acid or 1,14-tetradecanedioic acid Preferably it is 0.1 to 37.75 mol%, particularly preferably 5 to 35 mol%, and most particularly preferably 10 to 25.5 mol%, and/or the content of the dimer fatty acid having 36 carbon atoms is preferably 0.25 to 10 mol %, particularly preferably 1 to 7.5 mol%, and most particularly preferably 1.5 to 4.4 mol%.

非晶質或微晶聚醯胺(B)之相對黏度,根據ISO 307(2013)在20℃下,測定0.5g聚醯胺在100ml間甲酚中之溶液,較佳為1.35至2.15,特別較佳為1.40至2.00,以及最特別較佳為1.45和1.90。 The relative viscosity of amorphous or microcrystalline polyamide (B) is measured in accordance with ISO 307 (2013) at 20°C, a solution of 0.5 g polyamide in 100 ml m-cresol, preferably 1.35 to 2.15, especially It is preferably 1.40 to 2.00, and most particularly preferably 1.45 and 1.90.

成分(C)Ingredients (C)

術語填料(C)包括纖維狀(fibrous)或針狀填料(needle-shaped filler)、顆粒狀填料(particulate filler)及其混合物。 The term filler (C) includes fibrous or needle-shaped fillers, particulate fillers and mixtures thereof.

填料較佳可以被塗覆(coated)或表面處理,即,即其可以配備合適之上膠(sizing)或接著促進劑(adhesion promoter)系統或以其他方式被表面活化(surface activated)。為此目的,例如,可以使用基於胺甲酸乙酯(urethanes)、矽氧烷(silanes)、環氧樹脂(epoxides)、聚醯胺(polyamides)、聚羥基醚(polyhydroxy ethers)、丙烯酸酯(acrylates)、或其組合物或混合物之系 統。該上膠或接著促進劑(adhesion promoter)系統亦可以包括其它輔助物質,如抗靜電劑(antistatic agents)或潤滑劑(lubricants)。 The filler may preferably be coated or surface treated, that is, it may be equipped with a suitable sizing or adhesion promoter system or be surface activated in other ways. For this purpose, for example, based on urethanes, silanes, epoxides, polyamides, polyhydroxy ethers, acrylates, etc. can be used. ), or its combination or mixture System. The sizing or adhesion promoter system may also include other auxiliary substances, such as antistatic agents or lubricants.

該纖維狀或針狀填料較佳為選自由以下所組成之群組:玻璃纖維、碳纖維、玄武岩纖維(basalt fibers)、硼纖維(boron fibers)、礦渣纖維(slag fibers)、金屬纖維(metal fibers)、晶鬚(whiskers)、礦物纖維(mineral fibers)、矽灰石(wollastonite)、芳綸纖維(aramid fibers)、磨砂玻璃纖維(ground glass fibers)、磨砂碳纖維(ground carbon fibers)、磨砂礦物纖維(ground mineral fibers)及其混合物。纖維狀或針狀填料特別較佳為選自由以下所組成之群組:玻璃纖維、碳纖維、玄武岩纖維、硼纖維、芳綸纖維及其混合物。最特別較佳為,玻璃纖維專有地作為纖維狀或針狀填料被使用。 The fibrous or needle-shaped filler is preferably selected from the group consisting of glass fiber, carbon fiber, basalt fibers, boron fibers, slag fibers, and metal fibers. ), whiskers, mineral fibers, wollastonite, aramid fibers, ground glass fibers, ground carbon fibers, frosted mineral fibers (ground mineral fibers) and mixtures thereof. The fibrous or needle-shaped filler is particularly preferably selected from the group consisting of glass fiber, carbon fiber, basalt fiber, boron fiber, aramid fiber and mixtures thereof. Most particularly preferably, glass fibers are used exclusively as fibrous or needle-shaped fillers.

就玻璃纖維或碳纖維而言,可以使用短纖維(staple fibers)或連續細絲(continuous filaments)(粗紗(rovings))。 As for glass fibers or carbon fibers, staple fibers or continuous filaments (rovings) can be used.

玻璃纖維或碳纖維之橫截面為環狀(圓形)、卵形(oval)、橢圓形(elliptical)、具有壓縮(constriction)之橢圓形(所謂之繭狀纖維(cocoon fibers))、角形(angular)或矩形(rectangular)。具有非環狀截面之纖維,以及尤其是卵形、橢圓形、具有壓縮之橢圓形(所謂之繭狀纖維)、角形或矩形纖維,亦稱為扁平纖維(flat fibers)。亦可以使用環形和非環形纖維之混合物。 The cross-section of glass fiber or carbon fiber is ring (circular), oval, elliptical, constriction (the so-called cocoon fibers), angular (angular). ) Or rectangular. Fibers with non-annular cross-sections, and especially oval, elliptical, compressed elliptical (so-called cocoon fibers), angular or rectangular fibers, are also called flat fibers. It is also possible to use a mixture of circular and non-circular fibers.

玻璃纖維之外觀可以是拉長(elongated)或螺旋(spiral)形。 The appearance of glass fiber can be elongated or spiral.

可以使用由所有玻璃類型製成之玻璃纖維,如A-、C-、D-、E-、E-CR-、L-、LD-、M-、NE-、S-、R-、AR-玻璃或其任意之混合物。較佳為由E-玻璃、S-玻璃或包含E-及/或S-玻璃纖維之混合物製成之玻璃纖維。 You can use glass fibers made of all glass types, such as A-, C-, D-, E-, E-CR-, L-, LD-, M-, NE-, S-, R-, AR- Glass or any mixtures thereof. Preferably, they are glass fibers made of E-glass, S-glass, or a mixture containing E- and/or S-glass fibers.

玻璃短纖維(staple glass fibers)具有一纖維長度為1至50 mm,特別是1至25mm,較佳為1.5至20mm,特別較佳為2至12mm,以及最特別較佳為2至8mm。 Staple glass fibers have a fiber length of 1 to 50 mm, particularly 1 to 25 mm, preferably 1.5 to 20 mm, particularly preferably 2 to 12 mm, and most particularly preferably 2 to 8 mm.

玻璃纖維特別是具有5至20μm之直徑,較佳為5至15μm,以及特別較佳為6至12μm。 The glass fiber particularly has a diameter of 5 to 20 μm, preferably 5 to 15 μm, and particularly preferably 6 to 12 μm.

如果玻璃纖維在拉擠成形製程中(pultrusion process)作為連續細絲(粗紗)被使用,其較佳具有一直徑不大於20μm,較佳為不大於18μm,以及特別較佳為10至17μm。 If the glass fiber is used as a continuous filament (roving) in a pultrusion process, it preferably has a diameter of not more than 20 μm, preferably not more than 18 μm, and particularly preferably 10 to 17 μm.

碳纖維特別是具有3至12μm之直徑,較佳為4至10μm,以及特別較佳為4至9μm。 The carbon fiber particularly has a diameter of 3 to 12 μm, preferably 4 to 10 μm, and particularly preferably 4 to 9 μm.

在扁平纖維中,縱橫比(aspect ratio),即主要橫截面軸(major cross-sectional axis)與次要橫截面軸(minor cross-sectional axis)之比為1.5至8,較佳為2至6,特別較佳為2.5至5,以及最特別較佳為3至4。 In flat fibers, the aspect ratio, that is, the ratio of the major cross-sectional axis to the minor cross-sectional axis is 1.5 to 8, preferably 2 to 6. , Particularly preferably from 2.5 to 5, and most particularly preferably from 3 to 4.

在該等扁平纖維中,特別較佳為扁平玻璃纖維(flat glass fibers)。 Among these flat fibers, flat glass fibers are particularly preferred.

扁平玻璃纖維之橫截面軸長度為3至40μm。次要橫截面軸之長度較佳為3至20μm,特別較佳為4至10μ,以及主要橫截面軸之長度為6至40μm,特別較佳為12至30μm。 The cross-sectional axis length of the flat glass fiber is 3 to 40 μm. The length of the secondary cross-sectional axis is preferably 3 to 20 μm, particularly preferably 4 to 10 μm, and the length of the main cross-sectional axis is 6 to 40 μm, particularly preferably 12 to 30 μm.

顆粒狀填料較佳係選自以下所組成之群組:白雲石(dolomite)、矽酸鹽(silicates)、石英(quartz)、滑石(talc)、雲母(mica)、高嶺土(kaolin)、珍珠岩(perlite)、二氧化矽(silica)、沉澱或氣相二氧化矽(precipitated or fumed silica)、矽藻土(diatomaceous earth)、二氧化鈦(titanium dioxide)、碳酸鎂(magnesium carbonate)、氫氧化鎂(magnesium hydroxide)、 氫氧化鋁(aluminum hydroxide)、研磨或沉澱之碳酸鈣(ground or precipitated calcium carbonate)、白堊(chalk)、石灰(lime)、石灰石粉(lime stone powder)、板岩粉(slate powder)、長石(feldspar)、碳酸鋇(barium carbonate)、硫酸鋇(barium sulfate)、合成頁矽酸鹽(synthetic phyllosilicates)、天然頁矽酸鹽(natural phyllosilicates)、永久磁鐵(permanent magnet)或可磁化(magnetizable)之金屬或合金、玻璃片(glass flakes)、玻璃球(glass spheres)、空心玻璃球(hollow glass spheres)、空心二氧化矽球形填料(hollow silica sphere fillers)及其混合物。顆粒狀填料特別較佳係選自以下所組成之群組:矽酸鹽、石英、滑石、雲母、高嶺土、珍珠岩、二氧化矽、沉澱或氣相二氧化矽、矽藻土、二氧化鈦、碳酸鎂、氫氧化鎂、氫氧化鋁、研磨或沉澱之碳酸鈣、白堊、石灰、石灰石粉、板岩粉、長石、碳酸鋇、硫酸鋇、合成頁矽酸鹽、天然頁矽酸鹽、玻璃片、玻璃球、空心玻璃球、空心二氧化矽球形填料及其混合物。顆粒狀填料最特別較佳係選自以下所組成之群組:矽酸鹽、滑石、雲母、高嶺土、二氧化鈦、研磨或沉澱之碳酸鈣、白堊、石灰石粉、板岩粉、合成頁矽酸鹽、天然頁矽酸鹽、玻璃片、玻璃球、空心玻璃球及其混合物。 The particulate filler is preferably selected from the group consisting of dolomite, silicates, quartz, talc, mica, kaolin, perlite (perlite), silica, precipitated or fumed silica, diatomaceous earth, titanium dioxide, magnesium carbonate, magnesium hydroxide magnesium hydroxide), Aluminum hydroxide, ground or precipitated calcium carbonate, chalk, lime, lime stone powder, slate powder, feldspar feldspar, barium carbonate, barium sulfate, synthetic phyllosilicates, natural phyllosilicates, permanent magnet or magnetizable Metal or alloy, glass flakes, glass spheres, hollow glass spheres, hollow silica sphere fillers and mixtures thereof. The particulate filler is particularly preferably selected from the group consisting of silicate, quartz, talc, mica, kaolin, perlite, silica, precipitated or vapor phase silica, diatomaceous earth, titanium dioxide, carbonic acid Magnesium, magnesium hydroxide, aluminum hydroxide, ground or precipitated calcium carbonate, chalk, lime, limestone powder, slate powder, feldspar, barium carbonate, barium sulfate, synthetic phyllosilicate, natural phyllosilicate, glass flakes , Glass balls, hollow glass balls, hollow silica spherical fillers and their mixtures. The particulate filler is most particularly preferably selected from the group consisting of silicate, talc, mica, kaolin, titanium dioxide, ground or precipitated calcium carbonate, chalk, limestone powder, slate powder, synthetic phyllosilicate , Natural page silicate, glass flakes, glass balls, hollow glass balls and their mixtures.

較佳地,使用至少一纖維狀或針狀填料,或至少一纖維狀或針狀填料與至少一顆粒狀填料之混合物,作為根據本發明之聚醯胺模制化合物中之填料(成分(C))。 Preferably, at least one fibrous or acicular filler, or a mixture of at least one fibrous or acicular filler and at least one particulate filler is used as the filler in the polyamide molding compound according to the present invention (component (C )).

當使用至少一纖維狀或針狀填料與至少一顆粒狀填料之混合物時,顆粒狀填料之含量占填料總量不超過一半,較佳為不超過三分之一,以及特別較佳為不超過四分之一。 When a mixture of at least one fibrous or needle-shaped filler and at least one particulate filler is used, the content of the particulate filler accounts for no more than half of the total filler, preferably no more than one third, and particularly preferably no more than A quarter.

特別較佳為,纖維狀或針狀填料專門地作為根據本發明之聚醯胺模制化合物中之填料被使用。 It is particularly preferred that the fibrous or needle-shaped filler is used exclusively as the filler in the polyamide molding compound according to the present invention.

成分(D)Ingredients (D)

根據本發明之一較佳實施方案,至少一添加劑(D)係選自於以下所組成之群組:無機和有機穩定劑,尤其是抗氧化劑、抗臭氧劑(antiozonants)、光穩定劑(light stabilizers),尤其是紫外線穩定劑、紫外線吸收劑或紫外線阻擋劑(UV blockers)、潤滑劑(lubricants)、染料(dyes)、示踪劑(tracers)、顏料(pigments)、碳黑(carbon black)、石墨(graphite)、石墨烯(graphene)、碳奈米管(carbon nanotubes)、光致變色劑(photochromic agents)、抗靜電劑(antistatic agents)、脫模劑(release agents)、抗結塊添加劑(anti-block agents)、擴鏈添加劑(chain-extending additives)、縮鏈添加劑(chain-shortening additives)、光學增亮劑(optical brighteners)、紅外線吸收劑(IR absorbers)、近紅外線吸收劑(NIR absorbers)及其混合物。 According to a preferred embodiment of the present invention, at least one additive (D) is selected from the group consisting of inorganic and organic stabilizers, especially antioxidants, antiozonants, and light stabilizers. stabilizers, especially UV stabilizers, UV absorbers or UV blockers, lubricants, dyes, tracers, pigments, carbon black , Graphite, graphene, carbon nanotubes, photochromic agents, antistatic agents, release agents, anti-caking additives (anti-block agents), chain-extending additives, chain-shortening additives, optical brighteners, infrared absorbers, near-infrared absorbers (NIR) absorbers) and mixtures thereof.

在該等有機穩定劑中,特別較佳為苯酚化合物(phenol compounds)、亞磷酸化合物(phosphite compounds)、膦酸鹽化合物(phosphonite compounds)、基於受阻胺之穩定劑(hindered amine-based stabilizers;HALS)或其混合物。 Among the organic stabilizers, phenol compounds, phosphite compounds, phosphonite compounds, and hindered amine-based stabilizers (HALS) are particularly preferred. ) Or a mixture thereof.

至少一添加劑亦可以以母料(master batch)形式被加入。較佳為使用聚醯胺作為母料之基礎聚合物(base polymer)。該聚醯胺較佳為選自於以下所組成之群組:PA 12、PA 1010、PA 1012、PA 1212、PA 6/12、PA 612、PA MACM12及其混合物,或由聚醯胺(A)及/或聚醯胺(B)本身所組成。 At least one additive can also be added in the form of a master batch. Preferably, polyamide is used as the base polymer of the masterbatch. The polyamide is preferably selected from the group consisting of: PA 12, PA 1010, PA 1012, PA 1212, PA 6/12, PA 612, PA MACM12 and mixtures thereof, or is composed of polyamide (A ) And/or polyamide (B) itself.

母料之基礎聚合物最特別較佳為聚醯胺(A)或聚醯胺(B)本 身。 The base polymer of the masterbatch is most particularly preferably polyamide (A) or polyamide (B). body.

本發明將基於以下實施方案和實驗進行更詳細之描述,但不限制本發明於所示之具體實方案。 The present invention will be described in more detail based on the following embodiments and experiments, but does not limit the present invention to the specific embodiments shown.

成分(E)Ingredients (E)

根據本發明之一較佳實施方案,該至少一進一步之聚合物(E)係選自於外來聚合物(foreign polymers)、耐衝擊改質劑(impact modifiers)及其混合物所組成之群組。該至少一進一步之聚合物(E)特別較佳為選自於耐衝擊改質劑及其混合物所組成之群組。 According to a preferred embodiment of the present invention, the at least one further polymer (E) is selected from the group consisting of foreign polymers, impact modifiers and mixtures thereof. The at least one further polymer (E) is particularly preferably selected from the group consisting of impact modifiers and mixtures thereof.

測量方法Measurement methods

相對黏度(Relative Viscosity) Relative Viscosity

相對黏度是根據ISO 307(2007)在20℃下測定。為此目的,秤取0.5g聚合物顆粒到100ml間甲酚(m-cresol)中,依據標準之第11節(Section 11),根據RV=t/t0,計算相對黏度(RV)。 The relative viscosity is measured at 20°C according to ISO 307 (2007). For this purpose, weigh 0.5g of polymer particles into 100ml of m-cresol, and calculate the relative viscosity (RV) based on RV=t/t 0 according to Section 11 of the standard.

玻璃轉換溫度(Tg)和熔化溫度 Glass transition temperature (Tg) and melting temperature

根據ISO 11357-2和-3(2013),使用含水量小於0.1wt.%之顆粒進行測定。 According to ISO 11357-2 and -3 (2013), use particles with a water content of less than 0.1wt.% for measurement.

以加熱速率20K/min,對兩次加熱過程分別進行差示掃描量熱法(DSC)。第一次加熱過程之後,樣品在乾冰中淬火(quenched)。在第二次加熱過程中測定熔點。 Differential scanning calorimetry (DSC) was performed on the two heating processes at a heating rate of 20K/min. After the first heating process, the sample was quenched in dry ice. The melting point was determined during the second heating.

峰最大值(peak maximum)之溫度被指定為熔化溫度。根據「半高」技術確定玻璃轉換範圍(glass transition range)之中點,此即指定為 玻璃轉換溫度(Tg)。 The temperature of the peak maximum is designated as the melting temperature. Determine the midpoint of the glass transition range according to the "half-height" technique, which is designated as Glass transition temperature (Tg).

重量變化(Change in Weight) Change in Weight

重量之變化是在儲存之ISO拉伸棒上測定。 The change in weight is measured on a stored ISO stretch rod.

將僅儲存在水中之拉伸棒之重量變化從儲存在次氯酸鹽水溶液中之拉伸棒之重量變化減去。這樣,由於吸水而增加之重量就被消除了,吸水同樣在次氯酸鹽水溶液中儲存時發生。 The weight change of the stretch rod stored only in water is subtracted from the weight change of the stretch rod stored in the hypochlorite aqueous solution. In this way, the weight increase due to water absorption is eliminated, and water absorption also occurs during storage in an aqueous hypochlorite solution.

拉伸力(Tensile Force) Tensile Force

拉伸力是在儲存於次氯酸鹽水溶液中之ISO拉伸棒(A1型,量體170 x 20/10 x 4)上測定,係依據ISO/CD 3167(2003)標準所生產。 The tensile force is measured on an ISO tensile rod (Type A1, weighing 170 x 20/10 x 4) stored in an aqueous hypochlorite solution, which is produced in accordance with the ISO/CD 3167 (2003) standard.

測量方法類似於根據ISO 527(2012)在23℃下之拉伸強度(tensile strength)之測量方法進行,對未強化材料(unreinforced materials)使用牽引速率(pulling speed)為50mm/min,以及對強化材料(reinforced materials)使用牽引速率為5mm/min。絕對力(absolute force)直接被使用作為測量值,即不除以(division)試樣之橫截面(cross-sectional surface)。 The measurement method is similar to the measurement method of tensile strength at 23°C according to ISO 527 (2012). For unreinforced materials, a pulling speed of 50mm/min is used, and for reinforced materials The material (reinforced materials) uses a pulling rate of 5mm/min. The absolute force is directly used as the measured value, that is, it is not divided by the cross-sectional surface of the sample.

透光率(Light Transmission) Light Transmission

根據ASTM D 1003-13(2013),於23℃下,在厚度為2mm之60×60mm板子(寬度×長度)上和在Byk Gardner公司之「Haze Gard plus(曇度儀)」上之薄膜澆口(film gate),用CIE光源C(CIE illuminant C)確定透光率。透光率值係以照射光量之%表示。 According to ASTM D 1003-13 (2013), the film is poured on a 60×60mm board (width×length) with a thickness of 2mm at 23°C and on the "Haze Gard plus" of Byk Gardner. For film gate, CIE illuminant C is used to determine the light transmittance. The light transmittance value is expressed in% of the amount of irradiated light.

儲存條件(Storage Conditions) Storage Conditions

對兩種儲存類型在相同之時間點進行取樣,具體而言分別在每種情況下於1344小時(h)、4032小時、5376小時、6720小時和8064小時後。 對每種材料和儲存時間,5個ISO拉伸棒(A1型,量體170×20/10×4,依據標準:ISO/CD 3167(2003)所生產)被儲存,並找出5個測量值之算術平均值(arithmetic mean)。 The two storage types were sampled at the same time point, specifically after 1344 hours (h), 4032 hours, 5376 hours, 6720 hours and 8064 hours in each case respectively. For each material and storage time, 5 ISO stretch rods (type A1, weighing 170×20/10×4, according to the standard: produced by ISO/CD 3167 (2003)) are stored, and 5 measurements are found The arithmetic mean of the value.

水儲存係在恆溫器控制之60℃下,於去離子水中進行。 Water storage is carried out in deionized water at 60°C controlled by a thermostat.

次氯酸鹽儲存係在德國之克賴爾斯海姆(Crailsheim)之HyperDES-watertechnology GmbH公司之試驗台(test stand)中,於濃度為10mg/L之次氯酸鈉(sodium hypochlorite)水溶液,體積為100升,以恆溫器控制之60℃下而進行。次氯酸鈉溶液以6至8升/分鐘(L/min)在其中循環,其中溶液之pH值設定為6.8,以及電導率(conductivity)為600至1200μS。在總儲存時間內,藉由加入0.5wt%之次氯酸鈉溶液、0.7wt%之氫氧化鈉溶液(sodium hydroxide solution)、0.7wt%之硫酸(sulfuric acid)或去離子水,自動調節次氯酸鈉濃度、pH值和電導率。此外,每週使用CHEMATEST 20s儀器(可從瑞士之欣維爾(Hinwil)之Swan Analytische Instrumente AG公司獲得),根據DIN EN ISO 7393-2(2012),藉由使用N,N-二乙基-1,4-伸苯基二胺(N,N-diethyl-1,4-phenylenediamine)之比色法(colorimetric method)檢查pH值和次氯酸鈉濃度。 The hypochlorite is stored in the test stand of HyperDES-watertechnology GmbH in Crailsheim, Germany, in an aqueous solution of sodium hypochlorite (sodium hypochlorite) with a concentration of 10 mg/L and a volume of 100 The temperature rise is performed at 60°C controlled by a thermostat. The sodium hypochlorite solution circulates therein at a rate of 6 to 8 liters per minute (L/min), where the pH value of the solution is set to 6.8, and the conductivity is 600 to 1200 μS. During the total storage time, automatically adjust the concentration and pH of sodium hypochlorite by adding 0.5wt% sodium hypochlorite solution, 0.7wt% sodium hydroxide solution, 0.7wt% sulfuric acid or deionized water Value and conductivity. In addition, CHEMATEST 20s instrument (available from Swan Analytische Instrumente AG in Hinwil, Switzerland) is used every week, according to DIN EN ISO 7393-2 (2012), by using N,N-diethyl-1 , 4-Phenyl diamine (N, N-diethyl-1, 4-phenylenediamine) colorimetric method (colorimetric method) to check the pH value and sodium hypochlorite concentration.

試樣之製造(Production of the Test Specimens) Production of the Test Specimens

使用含水量小於0.1wt.%之顆粒來製造試樣。 Use particles with a moisture content of less than 0.1wt.% to make the sample.

ISO拉伸棒是在Arburg公司之型號為Allrounder 420 C 1000-250之一射出成型機上製造的。採用從進料到噴嘴之氣缸溫度(Cylinder temperatures)之上升和下降。 ISO stretch rods are manufactured on one of Arburg's model Allrounder 420 C 1000-250 injection molding machines. The rise and fall of cylinder temperatures from the feed to the nozzle are used.

實施例1和比較實施例2 Example 1 and Comparative Example 2

氣缸溫度:310/315/320/325/330/325℃ Cylinder temperature: 310/315/320/325/330/325℃

模具溫度(Mold temperature):120℃ Mold temperature: 120℃

實施例3、4和比較實施例5 Examples 3, 4 and Comparative Example 5

氣缸溫度:320/325/330/335/340/330℃ Cylinder temperature: 320/325/330/335/340/330℃

模具溫度:140℃ Mold temperature: 140℃

實施例6、7和8 Examples 6, 7 and 8

氣缸溫度:290/295/300/305/310/300℃ Cylinder temperature: 290/295/300/305/310/300℃

模具溫度:80℃ Mold temperature: 80℃

除非另有指示,試樣是在乾燥狀態下被使用;為此目的,在射出成型過程後,它們在乾燥環境中,即在矽膠(silica gel)上,於室溫儲存至少48小時。 Unless otherwise indicated, the samples are used in a dry state; for this purpose, after the injection molding process, they are stored in a dry environment, that is, on silica gel, at room temperature for at least 48 hours.

表1:實施例和比較實施例中使用之材料

Figure 109145569-A0202-12-0028-1
Table 1: Materials used in Examples and Comparative Examples
Figure 109145569-A0202-12-0028-1

Figure 109145569-A0202-12-0029-2
Figure 109145569-A0202-12-0029-2

表2:測試結果-重量變化%。

Figure 109145569-A0202-12-0029-3
Table 2: Test results-% weight change.
Figure 109145569-A0202-12-0029-3

Figure 109145569-A0202-12-0030-4
Figure 109145569-A0202-12-0030-4

表3:測試結果-拉伸力以N和以起始值之%表示。

Figure 109145569-A0202-12-0031-12
Table 3: Test results-the tensile force is expressed in N and in% of the initial value.
Figure 109145569-A0202-12-0031-12

Figure 109145569-A0202-12-0032-9
Figure 109145569-A0202-12-0032-9

從實驗中顯而易見地,令人驚訝地得知,只有包含半結晶聚醯胺(A)和非晶質聚醯胺(B)之混合物之該等聚醯胺模制化合物(實施例1、3、4和6至8)係對次氯酸鹼液(hypochlorite lye)穩定。 Obviously from the experiment, it was surprisingly learned that only these polyamide molding compounds containing a mixture of semi-crystalline polyamide (A) and amorphous polyamide (B) (Examples 1, 3) , 4 and 6 to 8) are stable to hypochlorite lye (hypochlorite lye).

令人驚訝地,得知在模製體於含次氯酸鹽之水溶液中儲存之期間,在包含半結晶聚醯胺(A)和非晶質聚醯胺(B)之混合物之聚醯胺模制化合物中,出現比僅包含半結晶聚醯胺(A)之聚醯胺模制化合物(比較實施例2和5)(表2)顯著較低之重量損失。重量之減少引起了聚醯胺模制化合物氧化降解(oxidative degradation)之假設,並因此對聚醯胺模制化合物造成損傷。因此,在根據本發明之實施例之聚醯胺模制化合物中,此種損傷比在比較實施例之聚醯胺模制化合物中顯著地較低。 Surprisingly, it is known that during the storage of the molded body in an aqueous solution containing hypochlorite, the polyamide containing a mixture of semi-crystalline polyamide (A) and amorphous polyamide (B) Among the molding compounds, the weight loss was significantly lower than that of the polyamide molding compounds containing only semicrystalline polyamide (A) (Comparative Examples 2 and 5) (Table 2). The reduction in weight leads to the hypothesis of oxidative degradation of the polyamide molding compound, and therefore damages the polyamide molding compound. Therefore, in the polyamide molding compound according to the embodiment of the present invention, such damage is significantly lower than that in the polyamide molding compound of the comparative example.

此結果係藉由測量與含次氯酸鹽溶液接觸後之拉伸力得到證實(表3)。與含次氯酸鹽溶液接觸後,包含半結晶聚醯胺(A)和非晶質聚醯胺(B)之混合物之聚醯胺模制化合物(實施例1、3、4和6至8),就拉伸力而言,比僅包含半結晶聚醯胺(A)(比較實施例2和5)之聚醯胺模制化合物顯示出顯著較佳之抗性。 This result was confirmed by measuring the tensile force after contact with hypochlorite-containing solution (Table 3). After contacting with hypochlorite-containing solution, polyamide molding compound containing a mixture of semi-crystalline polyamide (A) and amorphous polyamide (B) (Examples 1, 3, 4, and 6 to 8 ), in terms of tensile force, exhibits significantly better resistance than polyamide molding compounds containing only semi-crystalline polyamide (A) (Comparative Examples 2 and 5).

Claims (15)

一種聚醯胺模制化合物之用途,該聚醯胺模制化合物包括或由以下所組成: A use of a polyamide molding compound, the polyamide molding compound includes or consists of the following: 至少一半結晶聚醯胺(A);以及 At least half of the crystalline polyamide (A); and 至少一非晶質或微晶聚醯胺(B) At least one amorphous or microcrystalline polyamide (B) 用於生產對包含次氯酸及/或其鹽類之水溶液具耐受性之模製體。 Used to produce molded bodies that are resistant to aqueous solutions containing hypochlorous acid and/or its salts. 根據申請專利範圍第1項所述之用途,用於生產模製體,該模製體係選自於下列所組成之群組:用於輸送及/或儲存飲用水或溫水之部件;游泳池、漩渦池(whirlpools)、加熱系統中或衛生區(廚房、浴槽、蒸氣浴、盥洗室)中之部件;水龍頭;配件;外殼;混合器;分接頭(taps);過濾器外殼;水錶;水錶部件(軸承、螺桿(screw)、基座(pedestal));閥;閥部件(外殼、停止球(shut-off ball)、閘門(gate)、圓柱體(cylinders));分配器;濾罐(cartridges);泵;泵部件(動葉輪(impellers);觀察眼鏡(viewing glasses);蓋子;管線或容器(receptacles),以及其部件或元件。 According to the use described in item 1 of the scope of patent application, it is used to produce molded bodies. The molding system is selected from the group consisting of: parts for transporting and/or storing drinking or warm water; swimming pools, Parts in whirlpools, heating systems or sanitary areas (kitchens, baths, steam baths, toilets); faucets; accessories; housings; mixers; taps; filter housings; water meters; water meter components (Bearing, screw, pedestal); valve; valve parts (housing, shut-off ball, gate, cylinders); distributor; cartridges ); pump; pump components (impellers (impellers); viewing glasses; lids; pipelines or containers (receptacles), and its components or elements. 根據前述申請專利範圍中之任一項所述之用途,其特徵為,根據ISO 11537-3(2013)測量,該至少一半結晶聚醯胺(A)具有一熔化溫度為120至350℃。 The use according to any one of the aforementioned patent applications is characterized in that, measured according to ISO 11537-3 (2013), the at least half of the crystalline polyamide (A) has a melting temperature of 120 to 350°C. 根據前述申請專利範圍中之任一項所述之用途,其特徵為,根據ISO 11537-3(2013)測量,該至少一半結晶聚醯胺(A)之熔合熱為至少30J/g,特別較佳為至少35J/g,最特別較佳為至少40J/g,及/或 The use according to any one of the aforementioned patent applications, characterized in that, measured according to ISO 11537-3 (2013), the heat of fusion of the at least half of the crystalline polyamide (A) is at least 30 J/g, particularly higher It is preferably at least 35 J/g, most particularly preferably at least 40 J/g, and/or 根據ASTM D 1003-13(2013),在厚度為2mm之板子上測量之透光率係小於80%,較佳為小於70%,特別較佳為小於60%。 According to ASTM D 1003-13 (2013), the light transmittance measured on a board with a thickness of 2 mm is less than 80%, preferably less than 70%, and particularly preferably less than 60%. 根據前述申請專利範圍中之任一項所述之用途,其特徵為,該至少一半結晶聚醯胺(A)是由單體(a1)至(a2),以及任選之(a3)所形成: The use according to any one of the aforementioned patent applications, characterized in that the at least half crystalline polyamide (A) is formed from monomers (a1) to (a2), and optionally (a3) : (a1)至少一二胺,其係選自於以下所組成之群組:1,4-丁二胺(1,4-butanediamine)、1,5-戊二胺(1,5-pentanediamine)、1,6-己二胺(1,6-hexanediamine)、1,8-辛二胺(1,8-octanediamine)、1,9-壬二胺(1,9-nonanediamine)、1,10-癸二胺(1,10-decanediamin)、1,12-十二烷二胺(1,12-dodecanediamine)、2-甲基-1,5-戊二胺(2-methyl-1,5-pentanediamine)、2-甲基-1,8-辛二胺(2-methyl-1,8-octanediamine)、雙(4-胺基-環己基)甲烷(bis(4-amino-cyclohexyl)methane)、雙(胺基甲基)環己烷(bis(aminomethyl)cyclohexane)、異佛爾酮二胺(isophoronediamine)和間苯二甲胺(m-xylylenediamine)以及 (a1) At least one diamine, which is selected from the group consisting of 1,4-butanediamine (1,4-butanediamine), 1,5-pentanediamine (1,5-pentanediamine), 1,6-hexanediamine (1,6-hexanediamine), 1,8-octanediamine (1,8-octanediamine), 1,9-nonanediamine (1,9-nonanediamine), 1,10-decane Diamine (1,10-decanediamin), 1,12-dodecanediamine (1,12-dodecanediamine), 2-methyl-1,5-pentanediamine (2-methyl-1,5-pentanediamine) , 2-methyl-1,8-octanediamine (2-methyl-1,8-octanediamine), bis(4-amino-cyclohexyl)methane (bis(4-amino-cyclohexyl)methane), bis(4-amino-cyclohexyl)methane, bis(4-amino-cyclohexyl)methane, Aminomethyl) cyclohexane (bis(aminomethyl)cyclohexane), isophoronediamine (isophoronediamine) and m-xylylenediamine (m-xylylenediamine) and (a2)至少一二羧酸,其係選自於以下所組成之群組:1,6-己二酸(1,6-hexanedioic acid)、1,9-壬二酸(1,9-nonanedioic acid)、1,10-癸二酸(1,10-decanedioic acid,)、1,12-十二烷二酸(1,12-dodecanedioic acid)、1,13-十三烷二酸、1,14-十四烷二酸(1,14-tetradecanedioic acid)、1,15-十五烷酸(1,15-pentadecanoic acid)、1,16-十六烷二酸(1,16-hexadecanedioic acid)、1,17-十七烷二酸(1,17-heptadecanedioic acid)、1,18-十八烷二酸(1,18-octadecanedioic acid)、環己烷二羧酸(cyclohexanedicarboxylic acid)、具有36或44個碳原子之二聚脂肪酸、間苯二甲酸(isophthalic acid)和對苯二甲酸(terephthalic acid),及/或 (a2) At least one dicarboxylic acid, which is selected from the group consisting of 1,6-hexanedioic acid (1,6-hexanedioic acid), 1,9-nonanedioic acid (1,9-nonanedioic acid) acid), 1,10-decanedioic acid (1,10-decanedioic acid,), 1,12-dodecanedioic acid (1,12-dodecanedioic acid), 1,13-tridecanedioic acid, 1, 14-tetradecanedioic acid (1,14-tetradecanedioic acid), 1,15-pentadecanoic acid (1,15-pentadecanoic acid), 1,16-hexadecanedioic acid (1,16-hexadecanedioic acid) , 1,17-heptadecanedioic acid (1,17-heptadecanedioic acid), 1,18-octadecanedioic acid (1,18-octadecanedioic acid), cyclohexanedicarboxylic acid (cyclohexanedicarboxylic acid), with 36 Or 44-carbon dimerized fatty acid, isophthalic acid and terephthalic acid, and/or (a3)一或多種內醯胺或ω-胺基酸,其係選自於以下所組成之群組:內醯胺-6(lactam-6)、內醯胺-11(lactam-11)、內醯胺-12(lactam-12)、1,6-胺基己酸(1,6-aminohexanoic acid)、1,11-胺基十一酸(1,11-aminoundecanoic acid)和1,12-胺基十二酸(1,12-aminododecanoic acid)。 (a3) One or more lactams or ω-amino acids, which are selected from the group consisting of lactam-6 (lactam-6), lactam-11 (lactam-11), Lactam-12 (lactam-12), 1,6-aminohexanoic acid (1,6-aminohexanoic acid), 1,11-aminoundecanoic acid (1,11-aminoundecanoic acid) and 1,12- Aminododecanoic acid (1,12-aminododecanoic acid). 根據前述申請專利範圍中之任一項所述之用途,其特徵為,該至少一半結晶聚醯胺(A)係選自於以下所組成之群組:PA 6、PA 46、PA 49、PA 410、PA 411、PA 412、PA 413、PA 414、PA 415、PA 416、PA 417、PA 418、PA 436、PA 56、PA 510、PA 66、PA 69、PA 610、PA 611、PA 612、PA 613、PA 614、PA 615、PA 616、PA 617、PA 618、PA 1010、PA 66/6、PA 6/66/610、PA 6/66/12、PA 6/12、PA 11、PA 12、PA 912、PA 1212、PA MXD6、PA MXD9、PA MXD10、PA MXD11、PA MXD12、PA MXD13、PA MXD14、PA MXD15、PA MXD16、PA MXD17、PA MXD18、PA MXD36、PA MXD6/MXDI、具有4T重複單元之聚醯胺、具有5T重複單元之聚醯胺、具有6T重複單元之聚醯胺、具有8T重複單元之聚醯胺、具有9T重複單元之聚醯胺、具有10T重複單元之聚醯胺、具有12T重複單元之聚醯胺、PA 4T/6T、PA 4T/8T、PA 6T/8T、PA 4T/MPMDT、PA 4T/4I、PA 5T/5I、PA 6T/6I、PA 9T/MODT、PA 9T/9I、PA 10T、PA 10T/6T、PA 10T/6T/10I/6I、PA 12T、PA MPMDT/6T、PA 10T/10I、PA 12T/12I、PA 4T/6T/8T、PA 4T/6T/10T、PA 4T/8T/10T、PA6T/8T/10T、PA 4T/6T/MPMDT、PA 6T/6、PA 6T/66、PA 4T/66、PA 5T/66、PA 6T/6I/6、PA 10T/6T/1012/612、PA 6T/BACT、PA 66/BAC6/MACM6、PA 66/BAC6/PACM6、PA 66/BAC6/IPD6,及其混合物或共聚物。 The use according to any one of the aforementioned patent applications, characterized in that the at least half crystalline polyamide (A) is selected from the group consisting of: PA 6, PA 46, PA 49, PA 410, PA 411, PA 412, PA 413, PA 414, PA 415, PA 416, PA 417, PA 418, PA 436, PA 56, PA 510, PA 66, PA 69, PA 610, PA 611, PA 612, PA 613, PA 614, PA 615, PA 616, PA 617, PA 618, PA 1010, PA 66/6, PA 6/66/610, PA 6/66/12, PA 6/12, PA 11, PA 12 , PA 912, PA 1212, PA MXD6, PA MXD9, PA MXD10, PA MXD11, PA MXD12, PA MXD13, PA MXD14, PA MXD15, PA MXD16, PA MXD17, PA MXD18, PA MXD36, PA MXD6/MXDI, with 4T Polyamide with repeating unit, polyamide with 5T repeating unit, polyamide with 6T repeating unit, polyamide with 8T repeating unit, polyamide with 9T repeating unit, polyamide with 10T repeating unit Amine, polyamide with 12T repeating unit, PA 4T/6T, PA 4T/8T, PA 6T/8T, PA 4T/MPMDT, PA 4T/4I, PA 5T/5I, PA 6T/6I, PA 9T/MODT , PA 9T/9I, PA 10T, PA 10T/6T, PA 10T/6T/10I/6I, PA 12T, PA MPMDT/6T, PA 10T/10I, PA 12T/12I, PA 4T/6T/8T, PA 4T /6T/10T, PA 4T/8T/10T, PA6T/8T/10T, PA 4T/6T/MPMDT, PA 6T/6, PA 6T/66, PA 4T/66, PA 5T/66, PA 6T/6I/ 6. PA 10T/6T/1012/612, PA 6T/BACT, PA 66/BAC6/MACM6, PA 66/BAC6/PACM6, PA 66/BAC6/IPD6, and their mixtures or copolymers. 根據前述申請專利範圍中之任一項所述之用途,其特徵為,根據ISO 11537-3(2013)測量,該至少一非晶質或微晶聚醯胺(B)之熔合熱為不大於28J/g,特別較佳為不大於25J/g,最特別較佳為0至23J/g,及/或 The use according to any one of the aforementioned patent applications, characterized in that, measured according to ISO 11537-3 (2013), the heat of fusion of the at least one amorphous or microcrystalline polyamide (B) is not greater than 28J/g, particularly preferably not more than 25J/g, most particularly preferably 0 to 23J/g, and/or 根據ASTM D 1003-13(2013),在厚度為2mm之板子上測得之透光率為至少80%,較佳為至少85%,特別較佳為至少90%,及/或 According to ASTM D 1003-13 (2013), the light transmittance measured on a board with a thickness of 2mm is at least 80%, preferably at least 85%, particularly preferably at least 90%, and/or 根據ISO 11537-2(2013)測量之玻璃轉換溫度為60至240℃,較佳為80至230℃,特別較佳為105至210℃。 The glass transition temperature measured according to ISO 11537-2 (2013) is 60 to 240°C, preferably 80 to 230°C, particularly preferably 105 to 210°C. 根據前述申請專利範圍中之任一項所述之用途,其特徵為,該至少一非晶質或微晶聚醯胺(B)係由單體(b1)至(b2),以及任選之(b3)所形成: The use according to any one of the aforementioned patent applications, characterized in that the at least one amorphous or microcrystalline polyamide (B) is composed of monomers (b1) to (b2), and optionally (b3) Formed: (b1)至少一二胺,其係選自於以下所組成之群組:1,6-己二胺(1,6-hexanediamine)、1,10-癸二胺(1,10-decanediamine)、1,12-十二烷二胺(1,12-dodecanediamine)、2-甲基-1,5-戊二胺(2-methyl-1,5-pentanediamine)、間苯二甲胺(m-xylylenediamine)、雙(4-胺基-3-甲基環己基)甲烷(bis(4-amino-3-methylcyclohexyl)methane)、雙(4-胺基環己基)甲烷(bis(4-aminocyclohexyl)methane)、雙(4-胺基-3,5-二甲基環己基)甲烷(bis(4-amino-3,5-dimethylcyclohexyl)methane)、作為2,2,4-三甲基六亞甲基二胺(2,2,4-trimethylhexamethylenediamine)之雙(胺基甲基)環己烷ND(bis(aminomethyl)cyclohexane ND)、作為2,4,4-三甲基六亞甲基二胺(2,4,4-trimethylhexamethylenediamin) 之IND,以及 (b1) At least one diamine, which is selected from the group consisting of 1,6-hexanediamine (1,6-hexanediamine), 1,10-decanediamine (1,10-decanediamine), 1,12-dodecanediamine (1,12-dodecanediamine), 2-methyl-1,5-pentanediamine (2-methyl-1,5-pentanediamine), m-xylylenediamine ), bis(4-amino-3-methylcyclohexyl)methane, bis(4-aminocyclohexyl)methane , Bis(4-amino-3,5-dimethylcyclohexyl)methane (bis(4-amino-3,5-dimethylcyclohexyl)methane), as 2,2,4-trimethylhexamethylene bis Amine (2,2,4-trimethylhexamethylenediamine) bis(aminomethyl)cyclohexane ND (bis(aminomethyl)cyclohexane ND), as 2,4,4-trimethylhexamethylenediamine (2, 4,4-trimethylhexamethylenediamin) The IND, and (b2)至少一二羧酸,其係選自於以下所組成之群組:1,6-己二酸(1,6-hexanedioic acid)、1,10-癸二酸(1,10-decanedioic acid)、1,12-十二烷二酸(1,12-dodecanedioic acid)、1,14-十四烷二酸(1,14-tetradecanedioic acid)、1,16-十六烷二酸(1,16-hexadecanedioic acid)、1,18-十八烷二酸(1,18-octadecanedioic acid)、具有36或44個碳原子之二聚脂肪酸、環己烷二羧酸(cyclohexanedicarboxylic acid)、間苯二甲酸、對苯二甲酸和萘二甲酸(naphthalenedicarboxylic acid);及/或 (b2) At least one dicarboxylic acid, which is selected from the group consisting of: 1,6-hexanedioic acid (1,6-hexanedioic acid), 1,10-decanedioic acid (1,10-decanedioic acid) acid), 1,12-dodecanedioic acid (1,12-dodecanedioic acid), 1,14-tetradecanedioic acid (1,14-tetradecanedioic acid), 1,16-hexadecanedioic acid (1 ,16-hexadecanedioic acid), 1,18-octadecanedioic acid (1,18-octadecanedioic acid), dimerized fatty acids with 36 or 44 carbon atoms, cyclohexanedicarboxylic acid, isobenzene Dicarboxylic acid, terephthalic acid and naphthalenedicarboxylic acid; and/or (b3)一或多種內醯胺或ω-胺基酸,其係選自於以下所組成之群組:內醯胺-6、內醯胺-11、內醯胺-12、1,6-胺基己酸、1,11-胺基十一酸和1,12-胺基十二酸。 (b3) One or more endoamides or ω-amino acids, which are selected from the group consisting of endoamide-6, endoamide-11, endoamide-12, 1,6- Aminocaproic acid, 1,11-aminoundecanoic acid and 1,12-aminododecanoic acid. 根據前述申請專利範圍中之任一項所述之用途,其特徵為,該至少一非晶質或微晶聚醯胺(B)係選自於以下所組成之群組: The use according to any one of the aforementioned patent applications, characterized in that the at least one amorphous or microcrystalline polyamide (B) is selected from the group consisting of: PA 6I、PA 6I/6T、PA 10I/10T、PA MPMDI/MPMDT、PA 6I/6T/6N、PA MXDI/6I、PA MXDI/MXDT/6I/6T、PA MXDI/12I、PA MXDI、PA MXDI/MXD6、PA MACM10、PA MACM12、PA MACM14、PA MACM16、PA MACM18、PA NDT/INDT、PA TMDC10、PA TMDC12、PA TMDC14、PA TMDC16、PA TMDC18、PA PACM12、PA PACM14、PA PACM16、PA PACM18、PA PACM10/11、PA PACM10/12、PA PACM12/612、PA PACM12/PACM14/612/614、PA MACMI/12、PA MACMT/12、PA MACMI/MACM12、PA MACMI/MACMN、PA MACMT/MACM12、PA MACMT/MACMN、PA MACM36、PA TMDC36、PA MACMI/MACM36、PA 6I/MACMI/12、PA MACMT/MACM36、PA MACMI/MACMT/MACM36、PA MACMI/MACMT/12、PA 6I/6T/MACMI/MACMT、PA 6I/6T/MACMI/MACMT/12、PA MACM6/11、PA MACM6/12、PA MACM10/11、PA MACM10/12、PA MACM10/1010、PA MACM12/1012、PA MACM12/1212、PA MACM14/1014、PA MACM14/1214、PA MACM16/1016、PA MACM18/1018、PA 6I/6T/MACMI/MACMT/MACM12/612、PA 6I/6T/MACMI/MACMT/MACM12、PA MACMI/MACMT/MACM12/12、PA MACMI/MACMT/MACM12、PA 6I/6T/MACMI/MACMT/12、PA 6I/6T/6N/MACMI/MACMT/MACMN、PA TMDC12/TMDCT/TMDC36、PA TMDC12/TMDCI、PA TMDC12/TMDCI/TMDC36、PA TMDC12/TMDCT、PA 6I/6T/BACI/BACT、PA MACMI/MACMT/BACI/BACT、PA 6I/6T/MACMI/MACMT/BACI/BACT、PA MACMI/MACMT/MACM12/MACM36、PA MACMI/MACMT/MACM14/MACM36、PA MACMI/MACMT/MACMCHD/MACM36、PA TMDCI/TMDCT/TMDC12/TMDC36、PA TMDCI/TMDCT/TMDC14/TMDC36、PA TMDCI/TMDCT/TMDCCHD/TMDC36,及其混合物或共聚物, PA 6I, PA 6I/6T, PA 10I/10T, PA MPMDI/MPMDT, PA 6I/6T/6N, PA MXDI/6I, PA MXDI/MXDT/6I/6T, PA MXDI/12I, PA MXDI, PA MXDI/ MXD6, PA MACM10, PA MACM12, PA MACM14, PA MACM16, PA MACM18, PA NDT/INDT, PA TMDC10, PA TMDC12, PA TMDC14, PA TMDC16, PA TMDC18, PA PACM12, PA PACM14, PA PACM16, PA PACM18, PA PACM10/11, PA PACM10/12, PA PACM12/612, PA PACM12/PACM14/612/614, PA MACMI/12, PA MACMT/12, PA MACMI/MACM12, PA MACMI/MACMN, PA MACMT/MACM12, PA MACMT/MACMN, PA MACM36, PA TMDC36, PA MACMI/MACM36, PA 6I/MACMI/12, PA MACMT/MACM36, PA MACMI/MACMT/MACM36, PA MACMI/MACMT/12, PA 6I/6T /MACMI/MACMT, PA 6I/6T/MACMI/MACMT/12, PA MACM6/11, PA MACM6/12, PA MACM10/11, PA MACM10/12, PA MACM10/1010, PA MACM12/1012, PA MACM12/1212 , PA MACM14/1014, PA MACM14/1214, PA MACM16/1016, PA MACM18/1018, PA 6I/6T/MACMI/MACMT/MACM12/612, PA 6I/6T/MACMI/MACMT/MACM12, PA MACMI/MACMT/ MACM12/12, PA MACMI/MACMT/MACM12, PA 6I/6T/MACMI/MACMT/12, PA 6I/6T/6N/MACMI/MACMT/MACMN, PA TMDC12/TMDCT/TMDC36, PA TMDC12/TMDCI, PA TMDC12/ TMDCI/TMDC36, PA TMDC12/TMDCT, PA 6I/6T/BACI/BACT, PA MACMI/MACMT/BACI/BACT, PA 6I/6T/MACMI/MACMT/BACI/BACT, PA MACMI/MACMT/MACM12/MACM36, PA MACMI/MACMT/MACM14/MACM36, PA MACMI/MACMT/MACMCHD/MACM36, PA TMDCI/TMDCT/TMDC12/TMDC36, PA TMDCI/TMDCT/TMDC14/TMDC36, PA TMDCI/TMDCT/TMDCCHD/TMDC36, and their mixtures or copolymers , 其中基於100mol%之所有單體之莫耳分率之總和,MACM可以被最多為35mol%之PACM及/或TMDC取代,及/或 Wherein, based on the sum of the molar fractions of all monomers of 100 mol%, MACM can be replaced by PACM and/or TMDC up to 35 mol%, and/or 月桂脂內醯胺(laurin lactam)可以全部或部分地被己內醯胺(caprolactam)取代,及/或 Laurin lactam may be fully or partially substituted by caprolactam, and/or 具有36個碳原子之二聚脂肪酸可以全部或部分地被具有44個碳原子之二聚脂肪酸取代。 The dimer fatty acid having 36 carbon atoms may be substituted in whole or in part by the dimer fatty acid having 44 carbon atoms. 根據前述申請專利範圍中之任一項所述之用途,其特徵為,該聚醯胺模制化合至少另外包含至少一無機填料(C)及/或,任選地,至少一添加劑(D),及/或,任選地,至少一不同於聚醯胺(A)、聚醯胺(B)和不同於添加劑(D)之另外之聚合物(E)。 The use according to any one of the aforementioned patent applications, characterized in that the polyamide molding compound at least additionally contains at least one inorganic filler (C) and/or, optionally, at least one additive (D) , And/or, optionally, at least one polymer (E) different from polyamide (A), polyamide (B) and another polymer (E) different from additive (D). 根據前述申請專利範圍所述之用途,其特徵為,該聚醯胺模制化合物包含至少一無機填料(C),其係選自於纖維狀填料(fibrous filler)、針狀填料(needle-shaped fillers)及其混合物和組合物所組成之群組。 According to the use described in the aforementioned patent application, it is characterized in that the polyamide molding compound contains at least one inorganic filler (C) selected from fibrous fillers, needle-shaped fillers, and needle-shaped fillers. fillers) and their mixtures and compositions. 根據前述二項申請專利範圍中之任一項所述之用途,其特徵為,該聚醯胺模制化合物包含至少一無機填料(C),其係選自於玻璃纖維、碳纖維及其混合物和組合物所組成之群組。 The use according to any one of the aforementioned two patent applications, characterized in that the polyamide molding compound contains at least one inorganic filler (C), which is selected from glass fibers, carbon fibers and mixtures thereof and A group consisting of a composition. 根據前述申請專利範圍中之任一項所述之用途,其特徵為,該聚醯胺模制化合物具有以下成分: The use according to any one of the aforementioned patent applications is characterized in that the polyamide molding compound has the following ingredients: 19至95wt.%,較佳為25至89.39wt.%,特別較佳為21至67.9wt.%之至少一半結晶聚醯胺(A); 19 to 95 wt.%, preferably 25 to 89.39 wt.%, particularly preferably 21 to 67.9 wt.% of at least half of the crystalline polyamide (A); 5至60wt.%,較佳為10至50wt.%,特別較佳為15至30wt.%之至少一非晶質或微晶聚醯胺(B); 5 to 60wt.%, preferably 10 to 50wt.%, particularly preferably 15 to 30wt.% of at least one amorphous or microcrystalline polyamide (B); 0至70wt.%,較佳為0.1至60wt.%,特別較佳為15至50wt.%之至少一無機填料(C); 0 to 70wt.%, preferably 0.1 to 60wt.%, particularly preferably 15 to 50wt.% of at least one inorganic filler (C); 0至6wt.%,較佳為0.01至5wt.%,以及特別較佳為0.1至4wt.%之至少一添加劑(D);以及 0 to 6 wt.%, preferably 0.01 to 5 wt.%, and particularly preferably 0.1 to 4 wt.% of at least one additive (D); and 0至20wt.%,較佳為0.5至15wt.%,以及特別較佳為2至10wt.%之至少一聚合物(E); 0 to 20wt.%, preferably 0.5 to 15wt.%, and particularly preferably 2 to 10wt.% of at least one polymer (E); 成分(A)至(E)加總至100wt.%。 Ingredients (A) to (E) add up to 100wt.%. 根據前述申請專利範圍中之任一項所述之用途,其特徵為,該聚醯胺模制化合物至少另外包含至少一無機填料(C)及/或,任選地,至少一添加劑(D)。 The use according to any one of the aforementioned patent applications, characterized in that the polyamide molding compound at least additionally contains at least one inorganic filler (C) and/or, optionally, at least one additive (D) . 根據前述申請專利範圍所述之用途,其特徵為,該聚醯胺模制化合物具有以下成分: According to the use described in the scope of the aforementioned patent application, it is characterized in that the polyamide molding compound has the following ingredients: 19至95wt.%,較佳為25至89.89wt.%,特別較佳為31至69.9wt.%之至少一半結晶聚醯胺(A); 19 to 95 wt.%, preferably 25 to 89.89 wt.%, particularly preferably 31 to 69.9 wt.% of at least half of the crystalline polyamide (A); 5至60wt.%,較佳為10至50wt.%,特別較佳為15至30wt.%之至少一非晶質或微晶聚醯胺(B); 5 to 60wt.%, preferably 10 to 50wt.%, particularly preferably 15 to 30wt.% of at least one amorphous or microcrystalline polyamide (B); 0至70wt.%,較佳為0.1至60wt.%,特別較佳為15至50wt.%之至少一無機填料(C);以及 0 to 70wt.%, preferably 0.1 to 60wt.%, particularly preferably 15 to 50wt.% of at least one inorganic filler (C); and 0至6wt.%,較佳為0.01至5wt.%,特別較佳為0.1至4wt.%之至少一添加劑(D); 0 to 6wt.%, preferably 0.01 to 5wt.%, particularly preferably 0.1 to 4wt.% of at least one additive (D); 成分(A)至(D)加總至100wt.%。 Ingredients (A) to (D) add up to 100wt.%.
TW109145569A 2019-12-23 2020-12-22 Polyamide molding compounds for hypochlorite-resistant applications TW202134347A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EPEP19219339.9 2019-12-23
EP19219339.9A EP3842496A1 (en) 2019-12-23 2019-12-23 Polyamide moulding compositions for hypochlorite resistant applications

Publications (1)

Publication Number Publication Date
TW202134347A true TW202134347A (en) 2021-09-16

Family

ID=69005579

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109145569A TW202134347A (en) 2019-12-23 2020-12-22 Polyamide molding compounds for hypochlorite-resistant applications

Country Status (6)

Country Link
US (1) US11981813B2 (en)
EP (1) EP3842496A1 (en)
JP (1) JP2021098858A (en)
CN (1) CN113088071A (en)
MX (1) MX2020014210A (en)
TW (1) TW202134347A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115710428B (en) * 2022-09-29 2024-03-26 珠海万通特种工程塑料有限公司 Polyamide composite material and preparation method and application thereof

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4023968C2 (en) 1990-07-27 1994-10-27 Inventa Ag Amorphous copolyamide, process for its preparation and its use
DE4131028A1 (en) * 1991-09-18 1993-03-25 Basf Ag THERMOPLASTIC MOLDS BASED ON POLYAMIDE BLENDS
AU2004200856A1 (en) * 1998-10-23 2004-03-25 E.I. Du Pont De Nemours And Company Polyamide composition for molding
DE19913042C2 (en) 1999-03-23 2001-05-03 Inventa Ag Adhesion promoter for textile reinforcement inlays, manufacturing process and its use
EP1291073B1 (en) 2001-09-10 2005-03-23 Cognis Iberia, S.L. Polyamide Microcapsules
US8022170B2 (en) 2002-12-17 2011-09-20 Ems-Chemie Ag Copolyamides
DE10316873A1 (en) 2003-04-11 2004-11-11 Ems-Chemie Ag Flame retardant polyamide molding compounds
US20070083033A1 (en) * 2005-10-06 2007-04-12 Fish Robert B Jr Hydrolysis resistant polyamide compositions, and articles formed therefrom
DE102005052025B4 (en) 2005-10-31 2008-10-23 Ems-Chemie Ag Adhesive formulation, process for its preparation and its use
US8268956B2 (en) 2006-12-08 2012-09-18 Ems-Chemie Ag Transparent mold made of a polyamide molding material
EP2055743B2 (en) * 2007-10-30 2019-03-20 Ems-Patent Ag Moulding masses for manufacturing moulded parts in the drinking water sector
ATE492604T1 (en) * 2007-10-30 2011-01-15 Ems Patent Ag POLYAMIDE MOLDING COMPOUNDS, PARTICULARLY FOR THE PRODUCTION OF MOLDED PARTS IN THE DRINKING WATER SECTOR
EP2060607B2 (en) 2007-11-16 2019-11-27 Ems-Patent Ag Filled polyamide moulding materials
CH699310B1 (en) 2008-08-14 2012-03-30 Ems Patent Ag A process for preparing bridged dibenz [c, e] [1,2] oxaphosphorin-6-oxide.
CH699311B1 (en) 2008-08-14 2012-03-30 Ems Patent Ag A process for preparing dibenz [c, e] [1,2] oxaphosphorin-derivatives, amino-dibenz [c, e] [1,2] oxaphosphorin and the use thereof.
FR2941700B1 (en) * 2009-02-02 2012-03-16 Arkema France PROCESS FOR THE SYNTHESIS OF A BLOCK COPOLYMER ALLOY HAVING IMPROVED ANTISTATIC PROPERTIES
EP2290004B1 (en) * 2009-07-31 2016-08-31 Ems-Patent Ag Polyamide blend moulding material
PL2365033T3 (en) 2010-03-12 2013-12-31 Ems Patent Ag Impact-resistant modified polyamide moulding material and container made of same
EP2412757B1 (en) 2010-07-30 2013-11-13 Ems-Patent Ag Polyamide moulding composition for producing moulded articles with a soft touch surface and corresponding articles
EP2450389B1 (en) 2010-11-08 2015-03-18 EMS-Patent AG Adhesion promoter for textile reinforcing inserts and their use.
EP2460858B1 (en) * 2010-12-02 2014-01-22 EMS-Patent AG Polyamide moulding material on the basis of mixtures of transparent copolyamides and aliphatic homopolyamides for producing transparent moulded parts
EP2499932B1 (en) 2011-03-17 2016-05-11 EMS-Patent AG Casing body
SI2535365T1 (en) 2011-06-17 2014-02-28 Ems-Patent Ag Partially aromatic moulding masses and their applications
ES2452918T3 (en) 2011-11-24 2014-04-03 Ems-Patent Ag Flame retardant polymer fibers and their use as well as textile fabric containing these polymer fibers
EP2662398B1 (en) 2012-05-11 2014-07-16 Ems-Patent Ag Method for producing polysulfones and polysulfones
EP2662399B1 (en) 2012-05-11 2014-07-16 Ems-Patent Ag Method for producing polysulfones
EP2666803B1 (en) 2012-05-23 2018-09-05 Ems-Patent Ag Scratch-proof, transparent and ductile copolyamide moulding materials, moulded parts produced from same and use of same
EP2716716B1 (en) 2012-10-02 2018-04-18 Ems-Patent Ag Polyamide moulding compositions and their use in the production of moulded articles
EP2730563B1 (en) 2012-11-13 2017-01-11 Ems-Patent Ag Process for the preparation of MDI dimer
EP2746339B1 (en) 2012-12-18 2014-11-12 Ems-Patent Ag Polyamide form mass and moulded parts produced from same
EP2746341B2 (en) * 2012-12-21 2018-11-14 Ems-Patent Ag Stain-resistant articles and their use
EP2949704B1 (en) * 2012-12-21 2019-04-24 Ems-Patent Ag Discolouration-resistant articles and their use
EP2777919B1 (en) 2013-03-12 2022-06-22 Ems-Chemie Ag Method for the continuous production of laminates from fibre ribbons, and their use
EP2778190B1 (en) 2013-03-15 2015-07-15 Ems-Patent Ag Polyamide moulding material and moulded body produced from the same
EP2837643B1 (en) 2013-08-16 2018-10-10 Ems-Patent Ag Powder-form adhesion promoters that can be dispersed in water
DE102013217241A1 (en) 2013-08-29 2015-03-05 Ems-Patent Ag Polyamide molding compounds and moldings produced therefrom
EP2860009B1 (en) 2013-10-11 2019-01-09 Ems-Patent Ag Method for their manufacture of reinforced moulded items
EP3083805B1 (en) 2013-12-20 2019-02-20 EMS-Patent AG Long-fibre-reinforced polyamides
EP2902444B1 (en) 2014-01-31 2018-01-17 Ems-Patent Ag Polyamide moulding compounds with flame retardant properties and very good long-term heat ageing resistance
EP2927273B1 (en) 2014-04-02 2017-06-07 Ems-Patent Ag Polyamide moulding material, moulded parts produced from the same and use of the polyamide moulding material
EP2933295B1 (en) 2014-04-15 2016-07-06 Ems-Patent Ag Polyamide moulding material and its application
EP2952319B1 (en) 2014-06-06 2017-04-19 Ems-Patent Ag Method for low stress injection moulding of amorphous or microcrystalline polyamides
EP2957598A1 (en) 2014-06-20 2015-12-23 Ems-Patent Ag Composite containing a matrix material composed of an amorphous polyamide and its use
EP3020746B1 (en) 2014-11-11 2020-08-26 Ems-Patent Ag Polyamide moulding material, moulded article produced from same, and uses of same
JP6497823B2 (en) 2015-02-13 2019-04-10 エーエムエス−パテント アクチェンゲゼルシャフト Polyamide molding material and molded article produced from this molding material
EP3078475B1 (en) 2015-04-07 2019-01-30 Ems-Patent Ag Manufacturing method of a molded article reinforced with a reinforcing element
EP3135731B1 (en) 2015-08-31 2017-11-01 Ems-Patent Ag Polyamide moulding material and molded bodies made therefrom
EP3156435B1 (en) 2015-10-14 2019-07-24 Ems-Patent Ag Copolyamides, moulding compounds containing them and shaped articles produced therefrom
EP3168253B1 (en) 2015-11-13 2018-04-11 Ems-Patent Ag Flame retardant aliphatic polyketone masses, moulds obtained from these and method for preparing the same
EP3168252B1 (en) 2015-11-13 2019-01-09 Ems-Patent Ag Polyketone moulding materials with improved properties, moulded parts produced therefrom and method for its manufacture
EP3184278B1 (en) 2015-12-23 2019-04-17 Ems-Patent Ag Injection moulding method for the preparation of moulded parts, moulded part produced by means of injection moulding and injection moulding tool
EP3184577A1 (en) 2015-12-23 2017-06-28 Ems-Patent Ag Method and container for storing and transporting polyamide pellets and correspondingly stored or transported polyamide pellets and shaped articles obtained therefrom
US20190136053A1 (en) 2016-05-04 2019-05-09 Ems-Patent Ag Polyamide moulding composition and moulded article made therefrom
EP3309199B1 (en) 2016-10-12 2020-04-01 Ems-Patent Ag Glass filler reinforced polyamide molding materials based on amorphous copolyamides
EP3312224B1 (en) 2016-10-21 2018-12-26 Ems-Patent Ag Polyamide moulding composition and multi-layered structure made herefrom
EP3330319B1 (en) 2016-12-02 2020-08-26 EMS-Patent AG Polyamide moulding compounds with low relative permittivity
EP3369761B1 (en) 2017-03-03 2022-06-01 Ems-Chemie Ag Copolyamides comprising dimeric fatty acid as monomer
EP3392290B8 (en) 2017-04-18 2020-11-11 Ems-Chemie Ag Polyamide moulding material and molded bodies made from same
EP3444112B1 (en) 2017-08-18 2020-12-23 Ems-Chemie Ag Reinforced polyamide moulding compounds with low haze and moulds therefrom
EP3444113B1 (en) 2017-08-18 2021-01-20 Ems-Chemie Ag Reinforced polyamide moulding compounds with low haze and moulds therefrom
EP3444114B1 (en) 2017-08-18 2023-10-25 Ems-Chemie Ag Reinforced polyamide moulding compounds with low haze and moulds therefrom
EP3450481B1 (en) 2017-08-31 2020-10-21 Ems-Chemie Ag Polyamide moulding material having high gloss and high notch impact strength
EP3502164B1 (en) * 2017-12-22 2022-10-05 Ems-Chemie Ag Polyamide moulding material
EP3502191B1 (en) * 2017-12-22 2021-02-17 Ems-Chemie Ag Polyamide moulding material
EP3502188B1 (en) 2017-12-22 2020-08-19 EMS-Patent AG Use of a polyamide moulding material with low extract value for manufacturing moulded parts in the drinking water sector and resultant moulded articles
PL3597816T3 (en) 2018-07-19 2021-12-06 Ems-Chemie Ag Dipping bath compositions for treating reinforcement inserts
EP3597686B1 (en) 2018-07-19 2020-09-09 EMS-Patent AG Submersible bath compositions for treating reinforcement inserts
EP3636406B1 (en) * 2018-10-09 2021-04-28 Ems-Chemie Ag Toughened polyamide moulding masses
EP3670184A1 (en) 2018-12-20 2020-06-24 EMS-Patent AG Fluid transport line and its use

Also Published As

Publication number Publication date
US11981813B2 (en) 2024-05-14
US20210189124A1 (en) 2021-06-24
EP3842496A1 (en) 2021-06-30
JP2021098858A (en) 2021-07-01
MX2020014210A (en) 2021-06-24
CN113088071A (en) 2021-07-09

Similar Documents

Publication Publication Date Title
JP7327913B2 (en) Reinforced polyamide molding material with low haze and molding thereof
JP2019065262A (en) Low-haze reinforced polyamide molding material and molded body thereof
JP5689990B2 (en) Reinforced polyamide molding material using flat glass fibers and injection molded parts made with polyamide molding material
JP6705434B2 (en) Polyamide molding compound reinforced with glass filler based on amorphous copolyamide
US8586664B2 (en) Polyamide moulded masses containing semi-crystalline transparent copolyamides for producing highly flexible transparent moulded parts with high notch-impact strength, low water absorbency and excellent resistance to chemicals
ES2358132T3 (en) MOLDED MASSES OF HIGH TEMPERATURE POLYAMIDE REINFORCED WITH FLAT GLASS FIBERS.
JP6355586B2 (en) Polyamide molding material and use thereof
JP2019065261A (en) Low-haze reinforced polyamide molding material and its molded body
JP2016094601A (en) Polyamide molded material, molded article manufactured from the same and use purpose
JP5757973B2 (en) Transparent polyamide-imide
TWI772581B (en) Use of a polyamide molding compound having a low extract value for manufacturing moldings in the drinking water sector and corresponding moldings
JP2015042744A (en) Filled polyamide molding composition
US20180355151A1 (en) Polyamide moulding composition, in particular for the production of mouldings in the drinking water sector
KR101998532B1 (en) A semi-aromatic copolyamide resin and a polyamide molding composition comprising the same
TW202134347A (en) Polyamide molding compounds for hypochlorite-resistant applications
JP2017165935A (en) Transparent polyamide composition, molded body and method for producing the same
US20220195186A1 (en) Filled polyamide moulding compounds, moulded articles produced therefrom, and use of the filled polyamide moulding compounds
TW202132407A (en) Polyamide molding compounds for applications resistant to hypochlorite